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Résumé
Le méthylcyclopentadiényle manganèse tricarbonyle (MMT) est un dérivé organique de
manganèse (Mn) utilisé comme antidétonant dans l’essence sans plomb au Canada.
Plusieurs inquiétudes ont été soulevées quant à la neurotoxicité des principaux produits
de combustion du MMT, à savoir: le phosphate de Mn, le sulfate de Mn et un mélange de
sulfate/phosphate de Mn. L’objectif de cette recherche vise à évaluer et à comparer les
concentrations tissulaires à la suite d’une exposition subchronique par inhalation à des
particules d’un mélange de sulfate/phosphate de Mn chez des rats exposés à des
concentrations faible, moyenne et élevée. Cette recherche vise aussi à évaluer la
neuropathologie et les effets neurocomportementaux associés à l’exposition au mélange.
Ainsi, un groupe contrôle et trois groupes de 30 rats de $prague-Dawley mâles ont été
exposés dans des chambres d’inhalation, pendant 6 heures/jour, 5 jours/semaine durant 13
semaines consécutives. Les concentrations d’exposition étaient de l’ordre de 3000, 300, et
30 1g/m3. Pour l’étude de la neuropathologie, le décompte des cellules neuronales a été
réalisé au niveau du globus pallidus, du noyau caudé-putamen, et du cortex frontal. Quant
au changement neurocomportemental, il a été évalué à l’aide de l’activité locomotrice et
du tremblement. Pour ce faire, la moitié de chaque groupe des rats a été implantée avec
des électrodes EMG dans le muscle de gastrocnémien de la patte arrière. L’évaluation du
tremblement a été réalisée environ une heure après la dernière exposition pour une durée
approximative de 5 minutes quand le rat était au repos, quand il marchait et quand il était
en position verticale sur un écran grillagé de 39 cm.
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À la toute fin de l’étude, l’activité locomotrice a été évaluée pendant 36 heures en
utilisant un autotrack informatisé. Les rats ont ensuite été sacrifiés par exsanguination et
les concentrations de Mn dans les tissus (foie, poumon, testicule et rein), dans le sang et
dans le cerveau (noyau caudé- putamen, globus pallidus, bulbe olfactif, cortex frontal, et
le cervelet) ont été déterminées par activation neutronique.
Des concentrations plus élevées de Mn ont été observées dans le sang, le rein, le poumon,
le testicule et dans toutes les sections du cerveau chez le groupe le plus exposé. Le Mn
dans le poumon et dans le bulbe olfactif était dose-dépendant. Qui plus est, le bulbe
olfactif constitue la région du cerveau qui accumule davantage le Mn. Les paramètres
biochimiques sanguins ont révélé aussi quelques différences significatives entre les
groupes, en particulier pour la phosphatase alcaline, l’urée, et le chlorate.
L’activité locomotrice était significativement plus élevée chez les groupes exposés à 30
jtg/m3 et à 3000 jig/m3. Chez ce dernier groupe, on observe aussi une perte significative
de cellules neuronales dans les trois régions investiguées du cerveau. Par ailleurs, les
résultats n’indiquent aucun signe de tremblement. En conclusion, l’exposition à un
mélange de phosphate/sulfate de Mn entraîne des changements neuropathologiques au
niveau du cerveau et des effets neurocomportementaux chez les rats.
Mots-clés: mélange de phosphate/sulfate de manganèse, rats Sprague-Dawley, exposition
par inhalation, neuropathologie, effets neurocomportementaux
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Abstract
Methylcyclopentadienyl manganese tricarbonyl (MMT) is an organic manganese (Mn)
compound added to unleaded gasoline in Canada. The primary combustion products of
MMT are Mn phosphate, Mn sulfate, and Mn phosphate /sulfate mixture. Concems have
been raised that the combustion products ofMMT could be neurotoxic, even at low levels
of exposure. The objective of this study is to assess and compare tissue concentration
following subchronic inhalation exposure to a mixture of Mn phosphate/sulfate particles
in rats exposed at Ïow, intermediate and high levels. This research aims also to assess the
neuropathology and neurobehavioral effects associated with exposure to the mixture.
A control group and three groups of 30 male Sprague-Dawley rats were exposed in
inhalation chambers for a period of 13 weeks, 5 days per week, 6 hours a day. Exposure
concentrations were 3000, 300, and 30 pg/m3. The neuropathology aspect of this study
was to count neuronal celis in globus pallidus, caudate putamen, and frontal cortex. Also
the neurobehavioral change was measured by assessing locomotor activity and tremor
among groups. In each group, half of the rats were implanted with chronic EMG
electrodes in the gastrocnemius muscle of the hind lamb for the purpose of measuring
tremor. Tremor assessment was conducted one hour afier the last exposure by recording
muscle EMG activity for approximately 5 minutes with implanted EMG electrode rats
whule resting in the cage, walking on the floor, and standing on a vertical 39 cm metal
screen grid.
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At the end, locomotor activity test was conducted for 36 hours using a computerized
autotrack system. Rats were then sacrificed by exsanguinations, and Mn concentration in
different tissues (liver, lung, testis, and kidney), blood and brain (caudate putamen,
giobus pallidus, oifactory buib, frontal cortex, and cerebellum) were determined by
neutron activation analysis. Increased manganese concentrations were observed in blood,
kidney, lung, testis, and in ail brain sections in the highest exposure group. Mn in the
lung and in the oifactory bulb was dose-dependent. Our data indicate that the olfactory
bulb accumulated more Mn than other brain regions following inhalation exposure.
Biochemical profiles also reveaied some significant differences in certain parameters,
specifically aikaline phosphatase, urea, and chlorate.
Locomotor activity was significantly increased at 30 and 3000 jig/m3. The neuronal cell
loss was significantly different in ail three areas of interest for rats exposed to the highest
level of exposure (3000 p.g/m3). The result does flot show any sign of tremor. In
conclusion, exposure to Mn phosphate/sulfate mixture leads to onset the
neuropathological changes in particular area of the brain and causes some
neurobehaviorai differences among the rats.
Key words: Manganese phosphate/sulfate mixture, Sprague-DawÏey rats, inhalation
exposure, neuropathology, neurobehavioral effect
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CHAPTER I: Introduction
1.1 Manganese
Manganese (Mn) is a heavy metal that is an essential element in the diet of humans and
animais. Mn is widely distributed in the environment and can be found in rock, sou, air,
water, and food (WHO, 1999). Mn plays an important role for biologicai functions
including bone mineralization, metabolic regulation, celiular protection from damaging
by ftee radical species, and the formation of glycosaminoglycans. Mn can be found as a
component of over 100 minerais and does flot exist naturally in its pure form. It exists in
various forms as silicates, carbonates, phosphates. sulfides, borates and oxides (ATSDR,
2000).
Mn compounds are produced from Mn ores and they have a variety of applications.
Metallic Mn is used principally in steel production along with cast iron and superalloys to
improve hardness, stiffness, and strength in the production of manganese-iron alloy
(HSDB, 199$). Mn dioxide is commonly utilized in the production of dry-cell batteries,
matches, fireworks, and glass-bonding materials (U. S. EPA, 1984). Mn chloride is
employed as a precursor for other Mn compounds, as a catalyst in the chlorination of
organic compounds, and in animal feed (HSDB, 199$). Mn sulfate is used primariÏy as a
fertilizer, livestock supplement, ceramic, and fungicide. Potassium permanganate has
been used as an oxidizing agent, disinfectant, antialgal agent, metal cleaning, water
purifier, and a preservative for flowers and fruits (HSDB, 1998). Any ofthese uses may
result in the release of Mn to the environment.
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Mn compounds can exist as solids in the soi! and as solutes or small particles in water.
Most of the Mn saits are soluble in water except the phosphate and the carbonate (WHO,
1999). Mn exists in 11 oxidative states and the most common valences are +2, +4, and +
7 while the most stable and biologically important valence state is +2 (ATSDR, 2000).
Due to Iow vapor pressure, inorganic Mn compounds exist in the particu!ate matter
(NICNAS, 2003).
1.2 Sources and Level ofExposure
food is the most significant source of Mn exposure in the general population. The total
dietary Mn intake among individuals might vary depending upon nutritional intake. Most
people have a daily intake with a reported range of 0.9 to 10 mg per day (Finley and
Davis, 1999). Grains, tea, nuts, and green leafy vegetabÏes contain the highest amounts of
Mn. The daily intakes of 1 to 5 mg Mn from food have been estimated for humans to stay
healthy. The food and Nutrition Board has set an adequate intake level of Mn at 2.3
rng/day for men and 1.8 mg/day for women. The current recommendations for infants
and children are 0.03 to 0.6 and 1.2 to 1.9 mg/day, respectively (food and Nutrition
Board, 2002). The tolerabte upper intake level for Mn has been set at 11 mg/day, which is
the highest level of daily intake that is like!y to cause no adverse health effects in the
general population (food and Nutrition Board, 2002).
Mn represents about 0.1% of the earth’ s crust and it is a naturally occurring component of
ail sous in a range of 2 to 7000 mg/kg. Voicanic eruption and soit erosion can release Mn
into the atmosphere (Schroeder et al., 1987). Mn exists naturally in surface and
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underground water at low levels ranging ftom 0.4 to 10 mg/L. The primary sources for
surface and underground water Mn contamination are industriai facilities discharge,
Iandfihl disposai sites, and sou ieaching. Mn levei in water can be as high as 2000 mg/L
in areas close to industriai sources or waste disposai iands (ATSDR, 2000). Using
potassium permanganate in drinking water treatment, industrial wastewater purification
and odor abatement is another source of Mn release into water. The average Mn
concentration in drinking water ranges from 0.02 to 0.15 mg/L (EPA, 2002).
In addition to natural existence, Mn can be introduced into the environment by human
activity. The most important sources of Mn released into the air are industrial emissions
associated with ferroaiioy production, iron and steel foundries, power piant, coke oven,
and dust from uncontrolled mining operation (Lioy, 1983). Average Mn in urban and
rural areas without significant pollution sources is in the range of 0.01 to 0.007 tg/m3
(WHO, 1999). U.S. EPA has established a mean Mn background concentration of 0.04
jig/rn3 for urban area. According to data summarized by EPA, $0 % of U.S. cities have
Mn ieveis well beiow 0.1 tg/m3, and oniy 4.7 % have levels above 0.3 tg/m3. Higher
ambient leveis, up to 5 or even 10 lg/m3 occur near industriai point sources, such as steel
plants (EPA, 2002).
Another main source of inorganic Mn contamination in the urban environment is the
combustion of methylcyclopentadienyi manganese tricarbonyl (MMT) a fuel additive
used in unieaded automotive gasoline, particulariy in areas with high traffic density
(Joselow et al., 1978). The average atmospheric Mn concentrations measured in a high
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traffic area in Montreal were 0.05 and 0.024 tg!m3 for total and respirable (MnR)
fractions respectively (Loranger and Zayed, 1997; Zayed et al., 1999c).
According to a recent study in Montreal, the average outdoor MnR concentration in the
urban area (0.025 jig/m3) was significantly different compared to the rural area (0.005
tg/m3). Also, the indoor urban MnR concentration (0.017 .ig/m3) was significantly
different from indoor concentration in rural areas (0.007 tg/m3). This study has also
suggested that a higher outdoor atmospheric Mn concentration Ieads to higher indoor
concentration (Boité et al., 2004). Besides, in specific environments, such as houses near
highway, the atmospheric Mn concentration could exceed EPA’s reference concentration
(0.05 jiglm3) (Zayed et al., 1999a).
Another source of exposure to Mn is at the workplaces. The occupational exposure to Mn
is most likely occurring by inhalation of Mn fumes or dust. There is a potential for
workers to be exposed to Mn in the industrial facilities. For instance, workers in the
ferroalloy production sites, welding operations, and the dry battery manufacturing
facilities are exposed to Mn concentrations ranging from 300 to 20000 tg/m3. It has been
reported that the workers in mining operation are exposed to much higher Mn
concentrations, up to 45000 1g/m3 (Gibbs et al., 1999). Mn levels in certain workplace
environments such as garages are due to the use of MMI in gasoline. A study in
Montreal showed that blue-collar workers are exposed to mean Mn levels of 0.04 tg/m3,
while garage mechanics are exposed to 0.43 jig/m3 (Sierra et al., 1995).
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1.3 Toxicokinetics
Mn absorption occurs primarily from the gastrointestinal tract afier ingestion and from
the alveolar lining afier inhalation. The dermal absorption is flot a considerable route for
inorganic Mn since they caimot penetrate through the skin. The dermal pathway is most
likely important for absorption of organic Mn compounds such as maneb, mancozeb, and
MMT. Age, chemical species, dose, dietary condition, and route of exposure ail have an
effect on the extent and rate of Mn absorption and retention (Greger, 1999). Inhaled Mn
may be absorbed more rapidly and to a greater extent than ingested Mn (Ijalve et al.,
1996). The solubility of Mn species is another determinant of Mn absorption and
distribution (Roels et al., 1997).
1.3.1 Absorption
The animal studies indicated that important determinants of Mn absorption are the route
ofexposure and the chemical form of Mn (Smith et al., 1995; Tjilve et al., 1996; Roels et
al., 1997; Anderson et al., 1999). Under normal conditions, only about 3-5 % of ingested
Mn is absorbed by the gastrointestinal tract in the human body (finley et al., 1994). The
absorption of dietary Mn appears to be controlled by biliary excretion, intestinal
absorption, and intestinal elimination. Homeostatic mechanisms control the absorption of
Mn from the gut. There are many other factors that have been found to affect Mn
absorption, including dietary Mn level, dietary levels of various minerais, age and
developmental state of the individual and iron status (Greger, 1999). Low-protein and
iron-deficiency increase the absorption, whereas increased calcium and phosphorus levels
decrease Mn absorption (Murphy et al., 1991).
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The absorption of inhaled Mn is a function of particle size and its solubility. Particles
that are deposited in the lower airway are mainly absorbed, while particles deposited in
the upper airways may be moved by mucociliary transport to the throat, where they are
swallowed and enter the stomach. Thus Mn may be absorbed both from the lungs and in
the gastrointestinal tract following inhalation exposure (ATSDR, 2000).
Roels et al. (1997) measured Mn levels in blood following intranasal administration of
1.22 mg/kg as either MnC12 or Mn02 in rats. MnCl2, a soluble form, is quickly absorbed
into the blood compared to the insoluble Mn02. Blood Mn concentrations were increased
by 68% and 41 % following MnC12 and Mn02 exposure, respectively. Moreover, the
soluble particles were more readily delivered to the brain than insoluble Mn compounds
(Roels et al., 1997). Dorman et al. (2001) also reported that inhaled MnSO4 was cteared
from lung more rapidly than the less soluble phosphate or tetroxide compounds.
1.3.2 Distribution
The highest concentrations of Mn in the body with no excessive Mn exposure are found
in the liver, pancreas, adrenal gland, and kidney. The lowest concentrations are obsewed
in fat and bone (ATSDR, 2000). It has been suggested that tissues rich in mitochondria
may accumulate higher levels of Mn (Kato, 1963). Tjlve et al. (1996) investigated the
uptake of Mn in brain regions of rats following intranasal administration of 4 tg/kg. The
whole body autoradiography of rats at different time points indicated that the olfactory
bulb contained the highest concentration of Mn at 1, 3, and 7 days post-dosing (90, 69,
and 47 %, respectively), while the value decreased to 16 % afier 12 weeks. Significant
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uptake of Mn by other brain regions was flot observed until the third day, when the basal
forebrain, cerebral cortex, hypothalamus, and striatum had 21, 2, 3, and 1 % of the
labeled Mn, respectively. By contrast, liver and kidneys, each contained approximately 1
% ofmeasured Mn at 1, 3, and 7 days with values decreasing consistently after 12 weeks.
The absorbed Mn exists in divalent and trivalent states in the plasma ($cheumamer and
Cherian 1983). Both forms can enter the central nervous system via the blood-brain
barrier and the blood-cerebrospinal fluid barrier. Divalent Mn can be transported to brain
capillary endothelial ceils and choroidal epithelial celis via undefined transporters (Takeda,
2003). Mn may also circumvent the bÏood-brain barrier and pass directly into the central
nervous system via olfactory pathways (Tjalve et aï., 1996; frumkin and Solomon, 1997).
A large portion of divalent Mn may exist in non-protein-bound form as the free ion (May et
al., 1997). This free ion can be transported into the brain via calcium channels (Narita et al.,
1990) or tbrough Na and Ca exchange pathways (Frame et al., 1991). Trivalent Mn is able
to connect to transferrin and pass through the brain barrier via receptor-mediated
endocytosis. Mn entering the brain can combine with metalloproteins such as glutamine,
which are synthesized in astrocytes (Takeda et al., 2003).
Pharmacokinetic factors that may contribute to the increased efficiency of brain Mn
delivery following inhalation include greater Mn absorption from the lungs and slower
clearance of absorbed Mn from the circulation (Andersen et al., 1999). Moreover,
inhalation exposure to soluble forms of Mn resuits in higher brain Mn concentration
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compared with insoluble form of Mn (Dorman et al., 2001). Another study has shown
that afier intratracheal instillation, a surrogate for inhalation exposure, Mn concentrations
were higher in brain for soluble MnCI2 than for the insoluble Mn02. Striatal Mn
concentrations increased by 205% and 48% following MnC12 and Mn02 administration,
respectively (Roels et al., 1997).
Absorbed Mn is transported to other organs via the iron-binding protein transfenin, Œ2-
macroglobulin, and albumin. Manganese readily crosses the blood-brain barrier, and is
largely distributed to the central nervous system (Aschner et al., 1999). Following
chronic exposure to high level of Mn in humans and other primates, the metal
preferentially accumulates in the thalamic nuclei, substantia nigra, pallidum, and other
brain regions that also accumulate iron (Barbeau et al., 1984). Under normal plasma
concentrations, Mn enters the brain mainly across the cerebral capillaries. As the plasma
concentration increases, entry of Mn across the choroids plexus becomes more important
(Murphy et al., 1991).
1.3.3 Metabolism
Mn as a metallic element does flot go undergo metabolic transformation. Mn has a
potential to exist in a number of oxidation states in biological systems, and may transfer
from Mn (II) to Mn (III) in the body (ATSDR, 2000). The Œ-globulin protein,
ceruloplasmin, appears catalyze the alteration of Mn (II) to Mn (III) (Andersen et al.,
1999). The high affinity of the iron-transporting protein transfenmn for Mn (III) probably
enhances this reaction. Besides, small fraction of absorbed Mn exists as the free ion,
9
which readily forms complexes with some organic and inorganic ligands, albumins, and
proteins such as transfenin and a-macroglobulin (EPA, 2002). Mn also plays a role in
enzymatic reactions with hydrolases, kinases, transferases, and decarboxylases (Keen et
al., 1999; Lee, 2000).
1.3.4 Excretion
Several animal studies demonstrated that biliary/fecal excretion is the main route for Mn
elimination (Thompson et al., 1982; Davis et al., 1993; Malecki et al., 1996). In addition,
Mn might be excreted in the urine, pancreatic fluid, hair, sweat, and breast milk (WHO,
1981). Excretion of inorganic Mn from the body is rapid and does flot require active
processes. Most of inorganic Mn rapidly appears in the bile and feces, with a portion
undergoing enterohepatic recirculation.
Blood levels of Mn are increased in patients with impaired Mn clearance due to liver
dysfunction (Hauser et al., 1996). The biological haif-time in blood ranges from about 12
days in healthy miners to approximately 40 days in healthy volunteers (Mahoney and
$mall, 196$). Experiments in animais indicated that the elimination of Mn from the brain
is much siower compared with the whoie body (Newiand et al., 1989). Cotzias et ai.
(1968) demonstrated that the biologicai haif-time for intravenously injected Mn is 37.5
days in healthy subjects, 15 days in healthy miners, and 28 days in subjects with chronic
Mn exposure.
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Occupational exposure to high concentrations of Mn as well as hepatic failure appears to
alter Mn distribution in the central nervous system (Layrargues et al., 1995). People with
impaired clearance of Mn resulting from liver dysftmnction or portal systemic shunting
show increase of Mn concentration in the brain. The average 70 kg man carnes a total
body burden of about 12 to 20 mg of Mn. Iron status (assessed as serum concentration of
sodium ferritin) may possibÏy affect Mn excretion. The biological haif-time of Mn for
subjects with low ferritin was twice as of the rate determined for high ferritin status
subjects (Finley, 1999).
1.4 Health Effects
Mn is an important constituent of normal diet for humans and animals. Thus, at low
levels it has sorne beneficial effects while at higher levels of exposure via inhalation or
ingestion, it can cause adverse health effects to pulmonary, reproductive and nervous
systems (Komura and Sakamoto, 1991; Chang, 1996).
1.4.1 Beneficial Effects
Mn is a key element for normal physiological functioning in humans and all animal
species (U.S. EPA, 1996). It plays an important role in bone mineralisation, protein and
energy metabolism, metabolic regulation, celi protection from oxidative stress, and
nervous system function (ATSDR, 2000). Mn is a regulatory and catalytic factor for
enzymes including hydrolases, kinases, decarboxylases and transferases (Keen et al.,
1999).
Animal studies have demonstrated that Mn deficiency associated with some physiological
effects such as skeletal abnormalities, impaired growth, testicular degeneration, and
impaired reproductive function (Strause, 1986). Rats with low Mn in their diet
experienced more oxidation of mitochondrial membranes of the heart (Malecki and
Greger, 1996), and ultrastructural changes in the retina (Gong and Amemiya, 1996). Mn
deficiency has not been seen in the general population since human diet has relatively
high content of Mn. According to a human study, Mn deficiency may decrease level of
clotting proteins, serum cholesterol, retarded growth of hair and nails, and reddening of
black hair (Friedman et al., 1987).
1.4.2 Toxic Effects
Mn dust in different forms can irritate lungs of humans and animais and result in an
inflammatory response (Roels et al., 1987). There are significant adverse health effects
induced by Mn particulate inhalation in workers such as impotence and loss of libido
(AT$DR, 2000). The neurotoxic effects are primarily observed following chronic
inhalation exposure to high Mn concentration (Mergler et al., 1994). Ingestion of
contaminated well water (2 mg MnJL) has also been reported to induce neurological
effects (Kondakis et al., 1989). Since the inhaled Mn bypasses the typical excretory
mechanisms in the gastrointestinal tract it probably accumulates more in the brain and is
more available to the nervous system and other target organs. Therefore, inhaled Mn may
be more toxic than ingested Mn (Mirowitz and Westrich, 1992; ATSDR, 2000).
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1.4.2.1 Single Exposure
Studies in animais and humans indicate that the inorganic Mn compounds have very low
acute toxicity by any route of exposure. Acute inhalation exposure to high concentrations
of Mn dust (> 0.97 mg/m3) can cause an inflammatory response in the lung, which can
lead to impaired lung function in humans (Roels et al., 1987). This response however, is
characteristic ofnearly ail inhalable particulate matter (EPA, 2002) and not specific to the
Mn content of particles. Animal study has also revealed that acute inhalation exposure to
Mn oxide at high concentrations (>40 mg/m3) can induce respiratory effects and increase
susceptibiiity to pneumonia (Shiotsuka, 1984). The dermal pathway must also be
considered during spillage of MMT in gasoline on the skin.
Following single oral exposure, LD50 ranged from 275 to 804 mg/kg body weight for Mn
chloride in different rat strains. Also, LD50 from single exposure to Mn sulfate and Mn
acetate in rats were 782 and 1082 mg/kg body weight, respectively (Singh and Junnarkar,
1991). Age possibly plays a role in susceptibility to acute Mn toxicity. In an animal
study, it was found that Mn chioride induced greatest oral toxicity in the youngest than in
the oidest (Kostial et al., 1978). Data on the irritant and contact sensitivity properties of
Mn compounds are not available. The organic Mn compounds (MMT, mancozeb, and
maneb) have been reported to be sensitizers in animais (Thomas et al., 1990).
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1.4.2.2 Short-term Exposure
$hort-term inhalation exposure in animal studies shows that the lungs and nervous system
are the major target organs (Rodier, 1955). Inhalation exposure to 69 mg/m3 Mn dioxide
increased susceptibility to pneumonia (Maigetter et al., 1976). Subchronic inhalation
studies in animais have yielded NOAELs or LOAELs values for systemic (0.7 to 3.9
mg/m3), neurological (1.1 to 72 mg/m3). and reproductive effects (61 mg/m3). The range
of exposure levels associated with these effects is too wide to define a threshold. It has
been demonstrated that subchronic oral exposure of rats to MnC12 and MnSO4 (> 22
mg/kg) might induce the neurological, reproductive, and systemic effects (Desole et al.,
1994; Grant et al., 1997; Dorman et al., 2000). Systemic effects have been reported
following subchronic oral exposure to Mn sulfate (40 mg/kg) and Mn chloride (11
mg/kg) including changes in blood celi counts, reduced liver weight, and decreased body
weight in animais (Komura and Sakamoto, 1991).
1.4.2.3 Long-term Exposure
Available data from animal and epidemiological studies conceming the oral and the
inhalation exposure have suggested that the nervous system is the most sensitive target
for Mn (Mena et al., 1967; Wennberg et al., 1991). Chronic oral exposure to Mn (0.59
mg/L) in human has illustrated mild neuroÏogical signs (Kondakis et al., 1989). In
contrast, animal studies have determined that the oral exposure to Mn chloride and sulfate
may be associated with neurological (40 to 275 mg/kg) and reproductive effects (275
mg/kg) (Nachtman et al., 1986; Komura and Sakamoto, 1992). Chronic inhalation
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exposure to high concentrations of Mn-containing dust can induce adverse neurological
(0.027 to 5 mg/m3), respiratory (0.18 to 3.6 mg/m3), and reproductive (0.97 to 82.3
mg/m3) effects in humans (Iregren, 1990; Roles, et al., 1992; Wu et al., 1996).
1.4.2.3.1 Neurotoxicity
Occupational studies of miners, industrial and agricultural workers have established that
the lungs and brain are the primary target organs following chronic exposure to Mn. The
nervous system is the critical target organ of Mn toxicity. Long-term exposure to Mn in
occupational setting can resuit in a progressive neurological dysfunction, which can
produce a disabling syndrome referred to as manganism. Progression of manganism is
related to the dose and duration of exposure, as well as individual susceptibilities. The
striatum and associated brain structures are important target sites of Mn neurotoxicity in
humans (Came et al., 1994).
The clinical symptoms of manganism occur in three stages. The initial stage is subjective
and nonspecffic such as anorexia, apathy, asthenia, headaches, bad temper, and weakness
in the lower extremities. Gradually, an intermediate phase of developing neurological
signs associated with speech disturbance, facial expression, alterations of gait, loss of
balance, and fine tremor sets in. The final phase is characterized by persistent, ofien
irreversible neurological deficits characterized by muscle rigidity, a staggering gait,
dysphasia and a course intention tremor. Because some of these symptoms resemble
those of Parkinson’s disease, many investigators have used terms such as “Parkinsonism
like disease” (Rodier, 1955; Chang, 1996; Pal et al., 1999; Olanow et al., 2004).
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Although, symptoms of manganism look like those of Parkinson’s disease significant
differences have been noted. The tremor and hypokinesia present in patients suffering
from manganism are different from those seen in Parkinson’s disease (Barbeau, 1984).
Also psychiatric disturbances early in the disease such as “cock walk” and a propensity to
fali backward, less frequent resting tremor, more dystonia, and failure to respond to
dopaminomimetics are characteristics of manganism (Came et al., 1994; Olanow et al.,
2004).
There are some alterations in pathological findings between manganism and Parkinson’s
disease. Lesions in manganism are more distributed in the pallidum, the caudate nucleus,
the putamen, and even the cortex. In contrast, in Parkinson’s disease lesions are found in
the substantia nigra and other pigmented areas (Came et al., 1994). Using brain magnetic
resonance imaging (MRI) techniques, researchers have demonstrated that manganism
patients have elevated Mn concentrations in their basal ganglia, which has not been seen
in patients with Parkinson’s disease (Nagatomo et al., 1999). Mn can induce high signal
intensity on T1-weighted MRI that is related to its chemical property. The abnormality of
MRI signais has been reported in workers exposed to high concentrations of Mn (41.4%).
However, measurement obtained with this technique is qualitative rather than quantitative
(Kim, 2004).
More specific clinical signs of basal ganglia dysfunction characterize a slow or halting
speech without tone or inflection, a dull and emotionless facial expression, altered gait,
and fine tremor (Hochberg et al., 1996; Mergler and Baldwin, 1997). Severely affected
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manganism patients also develop progressive, irreversible loss of dopaminergic neurons
in globus pallidus and nigrostriatal pathway (Came et al., 1994).
Animal studies also revealed that chronic Mn exposure by the oral route could develop
muscular weakness and rigidity of the lower limbs. Oral exposure to Mn chloride in
rodents increases spontaneous locomotor activity, rigid and unsteady gait (Chandra et al.,
1983; Nachtman et ai.. 1986; Kristensson et al., 1986; Ah et al., 1995). The neurological
effects have been reported at lower airborne Mn concentrations in humans than in
animais (Newiand and Weiss, 1992). Although, there are dissimilarities in the variety of
neurological responses between animais and humans, it can be suggested that animal
modeis, mainly rodents, are likely useful for determining quantitative dose-response
relationships for neurological effects.
Occupational studies indicated that neurological symptoms were more significantly
associated with exposure to airbome Mn between 0.2 to 5 mg 1m3 for more than 20 years
(Crump and Rousseau, 1999; Gorehi et al., 1999). The alteration ofmotor effects has been
evidentiy attributed to an abnormal basal ganglia function (Huang et al., 1998). The
neuropathological feature of these symptoms includes neuronal loss in basal ganglia (Jog
et al., 1995).
1.4.2.3.2 Puimonary toxicity
Inhalation of particuiate Mn compounds such as Mn dioxide and Mn tetroxide leads to an
inftammatory response in human lungs. The symptoms of lung irritation and injury
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include bronchitis, cough, pneumonitis, and reduction in lung function (Roels et al.,
1987; Abdel-Hamid, 1990; Akbar-Khanzadeh, 1993). Increases in respiratory symptoms,
pneumonia and bronchitis have been reported among workers with occupational exposure
and in people living near manganese alloy production facilities (WHO, 1999). One study
has suggested an increase in prevalence of respiratory ilinesses in school chiidren
residing near a point source of atmospheric Mn pollution (Nogawa et al., 1973). A higher
incidence of pneumonia was observed arnong people living close to ferromanganese
factory as well as factory worker (Tanaka, 1994). The increased susceptibility to
respiratory infection might be related to the lung irritation and inflammation caused by
inhaled particulate Mn.
1.4.2.3.3 Reproductive and Developmental Toxicity
Limited data are available on developmental toxicity of Mn following oral exposures.
Several studies have reported developmental effects in animal models with orally
administered Mn. These studies show a decrease in serum testosterone, reduced fetal
body weight, and malformations in pups (Laskey et al., 1985; $zkmary et al., 1995;
Dorman et al., 2000). Male mice exposed to elevated dietary Mn (< 20 mg/kg) also show
decreased size of the testicles, seminal vesicles, and preputial glands, even without frank
neurological signs such as tremor and ataxia (Gray and Laskey, 1980).
Some inhalation data from occupational studies revealed that male reproductive
dysfunction is a major adverse health effect of Mn toxicity. The symptoms include loss of
libido and impotence (U.S. EPA, 1996). Impotence, loss of libido and decreased number
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of chiidren have been associated with male workers exposed to Mn dust for many years
(Laskey et al., 1985). A human study in an isolated island population with high Mn
intake, found an apparent excess of fetal malformations (Kilbum, 1987). Impaired
fertility has been observed in male workers exposed for 1-19 years to Mn dust at levels
(0.97 mg/rn3) that did flot produce any neurological effects (Lauwerys et al., 1985). No
information was found regarding reproductive effect in women.
1.5 Mechanisms ofToxicity
The mechanism of Mn-induced adverse effects has been studied for decades, but it is not
clearly established. Several hypotheses have been advanced to explain the relation
between Mn exposure and its neurotoxicity. It is clear that the main portais of Mn
absorption are the gastrointestinal tract and the lung (Aschner et al., 1991).
Absorbed Mn exists as divalent and trivalent Mn in plasma (Scheumamer and Cherian
1985). Both forms may distribute to the central nervous system via the blood-brain and
the blood-cerebrospinal ftuid barriers (Takeda, 2003). Mn may also circumvent ifie blood
brain barrier, and pass directly into the central nervous system via olfactory pathways
(Tjilve et al. 1996; Frumkin and Solomon, 1997). The olfactory bulb in rats can play a
significant role in the uptake of inhaled Mn and transport to brain (Tjiive et ai., 1999).
However, this route of Mn delivery to the brain is not clear in humans.
Divalent Mn can be transported into brain capillary endothelial ceils and choroidal epithelial
cells via undefmed transporters. It also appears that a large portion of divaient Mn exists in
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non-protein-bound forms as free ion (May et al., 1997). This free ion can be transported into
the brain via calcium channels (Narita et al., 1990) or through Na and Ca exchange
pathways (Frame et al., 1991). Trivalent Mn is able to bind to transferrin and be transported
across the brain barrier via the receptor-mediated endocytosis (Takeda et al., 2003).
When Mn enters the brain, it can bind to Mn metalloproteins such as glutamine, which are
synthesized in astrocytes. Several studies have documented that increased Mn
concentrations in the brain may alter the level and metabolism of neurotransmitters such
as dopamine, y-aminobutyric acid, and glutamate (Erikson et al., 2003). Glutamate is the
most common excitatory neurotransmitter, while -y-aminobutyric acid is the most
abundant inhibitory neurotransmitter. These neurotransmitters are responsible for the
control of motor behaviors (Carlsson, 1990). Astrocytes may play a key rote in Mn
induced neurological effects in the brain (Hazeli, 2002). Hazeil (2002) suggested that the
involvement of energy metabolism of mitochondria in astrocytes could cause the Mn
induced neuropathology.
Other studies have suggested that glutamate-mediated excitotoxicity may be responsible
for the neurological effects of Mn in the brain (Brouillet et al., 1993). HazelI and
Norenberg (1997) have studied the oxidant capacity of Mn in reduction of glutamate
uptake. In a further study, they found that increased Mn concentrations in the basal
ganglia could lead to oxidative damage in astrocytes, with a concomitant reduction of
glutamate uptake (Hazeil and Norenberg, 199$). Mn accumulation in the brain may
therefore cause major changes in astrocytes, including: reduction of glutamate uptake,
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reduction in mitochondria energy metabolism in astrocytes, increased excitotoxicity, and
proliferation of astrocytes. These effects may play a key role in impaired astrocytic
neuronal interaction, which resuits in neuronal celi death (Hazeli, 2002).
OveralÏ, brain Mn deposition is region-selective, being predominant in the basal ganglia,
which is involved in the control of movement arid of some cognitive functions. Acute
exposure to Mn is associated with an increase in dopamine neurotransmission, which is
also manifested as hyperactivity. Nevertheless, long-term exposure results in a loss of
dopamine in the brain, and the neuronal celi damage could be expressed as an increase in
motor activity or variation in neurobehavioral effects (Bonilla, 1984; Nachtman et al.,
1986).
1.6 Sensitive Population
Sensitive populations are defined as those that demonstrate an enhanced reaction to a
chemical compared with other exposed population. Sensitivity may be attributed to many
factors, for instance genetic, age, developmental stage, life style, and health status.
Infants and children with developing organs as well as the elderly with declining organ
function are expected to be more sensitive to Mn toxicity than healthy aduits. Mn is
excreted more rapidly in adults than in children (Fechter, 1999). Also there is evidence of
increased sensitivity for neurotoxic effects following Mn exposure in neonatal rats
compared to adult rats (Dorman et al., 2000).
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U.S. EPA (1996) has identified other sensitive subpopulations for Mn. These are groups
who may have greater potential for increased body burden due to increased absorption or
different excretion mechanisrn. However, pregnant women, elderly, iron or calcium
deficient individuals, and people with impaired liver function are considered as sensitive
population (Davis and Elias, 1996).
Patients with chronic liver disease could be more vulnerable to the neurotoxic effects of
Mn while they have a decrease in biliary excretion of Mn. In a study, portacaval
anastomosis (PCA) rats flot exposed to Mn, Mn content was increased in globus pailidus
by 57% and in caudate putamen by 67% compared to a control group (Therrien et al.,
1995). The relative influence of portal-systemic shunting and cholestasis on Mn
accumulation and neuronal cell loss in the brain was determined in rats with chronic liver
failure (Rose et al., 1999; Salehi et al., 2001). These studies indicated that compromised
Mn clearance might influence Mn bioaccumulation and Mn neurotoxicity. It has been
hypothesised that a relatively high exposure to Mn may be tolerated by normal animais and
humans but may lead to an overload and neurological problems in those with hepatic
dysfunction.
1.7 Public Health Concern
Mn toxicity is a well-recognized occupational hazard in human following exposure to
high concentrations of respirable Mn dust. Respiratory symptoms such as cough,
impaired pulmonary function, bronchitis, and pneumonitis (Roels et al., 199$) are related
to respirable Mn. Although the respiratory effects are important, the greatest public health
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concem is the neurotoxic effects such as manganism. Exposure to concentrations between
0.027 to 1 mg MnIm3 among miners and other industrial workers has been shown to
provoke adverse respiratory, neurological, and reproductive effects (Iregren, 1990;
Mergier et al., 1994; Lucchini et al., 1995).
The U.S. EPA has determined the potential health risks following exposure to Mn by
setting an inhalation reference concentration. The RfC for chronic inhalation exposure
was derived by using data ftom two epidemiological occupational studies (Roels et al.,
1987; Roels et al., 1992). The significant effect was destruction of neurobehavioral
function, as assessed by medical questionnaire, audio-verbal short-term memory, visual
reaction time, eye-hand coordination, and hand steadiness. According to Roels et al.
(1992), the LOAEL was identified to be 0.15 mg/m3 and the RfC was calculated by
dividing the LOAEL with a total uncertainty factor of i&, allowing 10 for each of the
following factors: 1) potentially greater susceptibility of the elderly and chiidren, 2)
extrapolation of LOAEL to NOAEL, 3) for chronic duration. Then the resuit was divided
by a factor of 3 for converting workday exposure (8 hr) to continuous exposure (24 hr),
which yielded 0.05 tg/m3 (U.S. EPA, 1996). This RfC is an estirnate ofa daily exposure
to human population that is likely to be without a signfficant risk during lifetime.
Presently, the public health concem of airbome Mn is increased due to the replacement of
lead with MMT. The use of MMI as a gasoline additive has led to an increase of
inorganic Mn, mainly Mn phosphate/sulfate mixture, Mn phosphate, and Mn sulfate in
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the atmosphere. Ihus, increased level of Mn in the air could lead to potential health risks
associated with chronic exposure.
Consequently, susceptible populations, such as children, individuals with chronic liver
disease, people with sub-optimal Mn or iron intake, and those with other medical states
(e.g., pre-parkinsonian state, aging) may have altered Mn metabolism and could be at
greater risk for Mn toxicity (Pujol et al., 1993; Spahr et al., 1996; Malecki et al., 1999).
Although, human data are most useful for the assessment of potential health hazards such
data conceming the long-term and low-level inhalation exposure to Mn species related to
MMI combustion products are not available. Consequently, to provide adequate
toxicological information on Mn species for risk assessment purposes, it is necessary to
develop dose-response data using animal models.
1.8 Specific Concern Related to MMI
MMI (C9H7MnO3) was developed by the Ethyl Corporation in the 1950s. MMI is an
organometallic compound used as an antiknock agent in intemal combustion engine fuels
to increase the octane level of gasoline and therefore to improve the antiknock properties
ofthe fuel (Davis, 199$). MMI has been used in the United States since 1976. Although
in 1977, the adoption of the Clean Air Act limited the use of MMT to gasoline and U.S.
EPA denied Ethyl’s waiver for the use of MMT until October 1995, when a court
decision allowed the company to offer it for sale to refiners for use in unleaded gasoline
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and since that time MMT has been used freely (Wallace and Slonecker 1997, Landrigan,
2001).
The use of MMI in gasoline has been permitted in Canada since 1978 (Health and
Welfare Canada, 1978). Its use increased steadily until it completely replaced tetraethyl
lead in gasoline in 1990 (Hurley et al., 1992). Since 1997, trade of MMT was limited in
Canada under the Mn-based Fuel Additive Act that effectively banned the importation of
MMI into Canada. Eventually in 1998, the Govemment of Canada had removed
restriction and continues to use it (Davis, 1998).
MMI is allowed to use in France (Ministre de L’Aménagement du Territoire et de
L’Environnement, 1999), UK (British Standards Institute, 1999), China (China State
Bureau of Quality and Technology Supervision, 2000), Russia (Ministiy of Fuel and
Energy of Russian Federation, 1997), and Argentina (Norma Argentina, 1999). In New
Zealand, according to the Petroleum Products Specification Regulations 2002,
automotive fuel must contain no more than 2.0 mg MnIL.
Usually, 72 mg MMT/L is used in gasoline that corresponds to 1$ mg MnIL (Garrison et
al., 1995). The maximum concentration of MMT allowed by the U.S. EPA is 8.3 mg
MnJL of gasoline. According to Health Canada, MMI is currently used in 80% of
Canadian gasoline at various concentrations and the mean concentration is approximately
10 mg MnIL (Wood and Egyed, 1995). However, Zayed and colleagues have found that
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the MMT-added gasoline in Canada has a mean concentration of 6.5 mg MnJL (Zayed et
al., 1999c).
MMT is marketed as AK-33X (antiknock agent-33X) or Hilec 3062 (Jaques, 1987). It is
a yellow, volatile liquid that has a very low vapor pressure at room temperature (0.05
mmHg @ 20°C) and is completely miscible in gasoline and very slightly soluble in
water. MMT is extremely unstable in light and degrades rapidly in air; thus, exposure via
gasoline exhausts is expected to be more to the oxidative products such as Mn oxides,
phosphate, and sulfate rater than to the parent compound (Garrison et al., 1995; Ressier,
2000; Molders et al., 2001; NICNAS, 2003).
Generally, the combustion products of MMT depend on fuel composition, engine and
catalytic converter thermodynamics. The actual portion of Mn emitted is also very variable
and depends on various factors including, overail distance driven and driving condition
(urban vs. highway) (Ardeleanu et al., 1999).
More recently, samples of particles emitted from several cars that has accumulated
significant mileage on MMT-additive gasoline determined that there were tbree maj or Mn
compounds including a mixture of Mn phosphate, Mn5(P04)2[P03-(OH)]2.4H20,
MnSO4.H20, and Mn304 (Ressler et al., 2000; Molder et al., 2001). The ratio for each
compound is dependent on the driving cycle and vehicle, however the percentage of
combusted product stays relatively constant with the 80% of Mn phosphate and sulfate
and less then 20 % of Mn oxide (Pfeifer et al., 2004).
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It is also recognized that most ofthe emitted Mn in the form ofphosphate/sulfate mixture
in the tailpipe has particle sizes ranging between 0.2 and 10 im (Zayed et al., 1994;
Zayed et al., 1 999b). More than 99 ¾ of Mn particles are in the respirable fraction (< 5
im) and 86 % are smaller than 1 im (Ardeleanu et al., 1999; Zayed et al., 1999b). In
conclusion, Mn particles emitted from MMT are more likely to reach the alveolar region.
Many studies have established a positive relation between traffic density and Mn
concentrations in the biotic and abiotic components of ecosystem (Loranger et al., 1996;
Zayed et aÏ., 2003). Ardeleanu suggested that motor vehicles would add 350 tons of Mn
into the Canadian environment each year (Ardeleanu et al., 1999). The U.S. EPA (1994)
estimated that if MMT used in gasoline increases by 100%, the level of Mn in ambient air
will increase to 0.1 tg/m3, way more than the RfC.
Nevertheless, exposure of the general population to Mn originating ftom MMT seems to
be negligible compared to the contribution of the Mn from other industrial and natural
sources (Loranger and Zayed, 1997). However, experience with lead in gasoline
demonstrated that significant widespread exposure of the general population might occur
by adding relatively small amounts of a substance to gasoline (Davis et al., 1996). To
determine the risk posed to general population by inhaled Mn species, it is required to
have more information about the potential toxicological hazards and the accepted levels
of exposure.
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1.9 Objectives
The main hypothesis in this study is that the exposure to Mn phosphate/sulfate mixture may
resuit in different bioaccumulation, neuropathological, and neurobehavioral changes that
could be dose-dependent. The objectives of this study are to evaluate the effects of Mn
phosphate/sulfate mixture on $prague-Dawley rats at low (30 jiglm3), intermediate (300
j.tg/m3) and high levels (3000 jig/m3) on:
the deposition and the bioaccumulation of Mn in different tissues and organs,
> the blood biochemical parameters,
the neurobehavioral status (locomotor activity and muscular tremor), and
> the neuropathology effect in the brain.
The resuits of this study may correspond to another step forward to better understand the
relationship between exposure and nervous system affects for Mn compounds resulting
from the use of MMI in gasoline.
1.10 Special Consideration in this Study
To date, studies to evaluate the neurotoxic effects following inhalation exposure to Mn
phosphate/sulfate mixture have not been undertaken. This mixture is the primary
combustion product of MMT, receiving increased attention in relation to environmental
contamination and public health. This study is unique in that it is the first study to
investigate the adverse effects of the Mn phosphate/sulfate mixture following inhalation,
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which is the main route of exposure associated with neurotoxicity of Mn in humans and
animais.
In this study, equal weights of Mn phosphate and Mn sulfate were introduced into the
inhalation chamber. However, the subsequent analysis of air samples by electron
microscopy showed that 39 % of the particles were Mn sulfate and 61 % were Mn
phosphate. This ratio is acceptable since it is near the ideal ratio of 1:1. Prior to the
experiment, the molecular weight (MW) of each substance was taken into account to
maximize the probability of obtaining a ratio of 50:50 for particles in the inhalation
chamber. Since the MW was 728.65 and 169.03 for Mn phosphate and Mn sulfate
respectively, representing a ratio of approximately 4:1, the inverse ratio was used for w/w
(4 Mn sulfate / 1 Mn phosphate). Nevertheless, the proportion of particles for each Mn
species was far away from the target of 1:1. In fact, more than $0 % of the particles were
related to Mn sulfate compound. The details can be found in the report of Beaupré et al.
(2004) in the Appendix ofthis thesis.
The exposure level of 3000 ig/m3 was derived from the inhalation study of Coulston and
Griffin (1977) that used 100 jtg/m3 of Mn compounds for 24 br. Thus, 3000 j.ig/m3 was
derived by multiplying 100 jtg/m3 with 3 (24/8) and a correction factor of 10 in
consideration of exposure duration. b help adequately evaluate the dose-response
relationship in subchronic study, this level of exposure was divided by a factor of 10
sequentially, which yielded 300 and 30 tg/m3.
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Human exposure to high levels of Mn in mining and occupational exposure has been
reported to induce neurobehavioral and neuropathological effects. Experimental studies in
rodent and other anina1 species have been carried out to produce these effects. Rats seem
to be a usefu! mode! to study neurotoxicity effects of Ivin and its compounds (Russeli,
1991).
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2.1 Abstract
Methylcyclopentadienyl manganese tricarbonyl (MMT) is an organic manganese (Mn)
compound added to unleaded gasoline in Canada. Ihe primary combustion products cf
MMI are Mn phosphate, Mn sulfate, and a Mn phosphate /sulfate mixture. Concems have
been raised that the combustion products of MMT containing Mn could be neurotoxic,
even at low levels cf exposure. The objective cf this study is to investigate exposure
response relationships for bioaccumulation and locomotor effects following subchronic
inhalation exposure to a mixture cf manganese phosphates/sulfate mixture. A control
group and three groups cf 30 male $prague-Dawley rats were exposed in inhalation
chambers for a period cf 13 weeks, 5 days per week, 6 hours a day. Exposure
concentrations were 3000, 300, and 30 1g/m3. At the end cf the exposure period,
locomotor activity and resting time tests were conducted for 36 h using a computerized
autotrack system. Rats were then sacrificed by exsanguination and Mn concentrations in
different tissues (liver, lung, testis, and kidney), blood and brain (caudate putamen,
globus pallidus, olfactory bulb, frontal cortex, and cerebellum) were determined by
neutron activation analysis. Increased manganese concentrations were observed in blood,
kidney, lung, testis, and in all brain sections in the highest exposure group. Mn in the
lung and in the olfactory bulb was dose-dependent. Our data indicate that the olfactory
bulb accumulated more Mn than other brain regions following inhalation exposure.
Locomotor activity was increased at 30 and 3000 j.ig/m3, but no difference was observed
in resting time among the exposed groups.
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At the end of the experiment, rats exposed to 300 and 3000 jig/m3 exhibited significantly
decreased body weight in comparison with the control group. Biochemical profiles also
revealed some significant differences in certain parameters, specifically aikaline
phosphatase, urea, and chlorate. This study is one of several ongoing studies in our
laboratory that address the toxicity of different Mn species.
Keywords: Manganese phosphate/sulfate mixture, inhalation exposure, Sprague-Dawley
rats, bioaccumulation, locomotor activity
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2.2 Introduction
Methylcyclopentadienyl manganese tricarbonyl (MMT) is one of the main sources of
inorganic manganese contamination in urban air, mainly in areas with high traffic density
(Joselow et al. 1978). The main combustion products of MMT are essentially Mn
phosphate, Mn-sulfate, and Mn-phosphate/sulfate mixture (Zayed et al., 1999). Exposure
to high concentrations of atmospheric Mn can lead to adverse health outcomes, notably
respiratory and neurological effects. Exposure to concentrations >1 mg Mnm3 among
miners and other industrial workers has been shown to persuade adverse respiratory,
neurological, and reproductive effects (Iregren, 1999).
The clinical syndrome of manganese neurotoxicity (manganism) can be divided into an
early phase characterized by obvious mood and behavior changes, and a later stage
somewhat similar to Parkinson’s disease that is characterized by dystonia and severe gait
disorder (Pal et al., 1999). However, little is known about the potential health effects that
may result from long-term low-level exposure of populations through ambient air.
Certain subpopulations such as children and patients with chronic liver disease could be
more susceptible to different levels of Mn contamination.
It is clear that the route of exposure can influence the distribution, metabolism, and
potential for neurotoxicity of Mn-containing compounds (Roels et al., 1997). Inhalation
exposure is more efficient than ingestion at transporting Mn to the brain.
Pharmacokinetic factors that may contribute to the increased efficiency of brain Mn
delivery following inhalation include greater Mn absorption from the lungs and siower
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clearance of absorbed Mn from the circulation (Andersen et al., 1999). Moreover,
inhalation exposure to soluble forms of Mn results in higher brain Mn concentration
compared with insoluble form of Mn (Dorman et al., 2001). One study has shown that
after intratracheal instillation, a surrogate for inhalation exposure, Mn concentrations
were higher in brain following the administration of the soluble salt MnCl2, than
following the administration of the insoluble oxide Mn02. $triatal Mn concentrations
increased by 205% and 48% following MnC12 and Mn02 administration, respectively
(Roels et al., 1997).
The main brain target for Mn toxicity is the basal ganglia (caudate nucleus, globus
pallidus, and putamen), which is involved in motricity. Disturbances of the basal ganglia
can lead to unintentional contraction of the skeletal muscles, such as tremor and muscular
rigidity, as in Parkinson’s disease. f ew studies have been conducted to describe the
distribution of brain Mn following inhalation of different Mn species, the main route by
which Mn intoxication occurs in workers. It seems likely that the neurotoxicity of inhaled
manganese possibly be related to an uptake of this metal into the brain via olfactory
neurons. The olfactory bulb in rats can make a significant role to uptake of inhaled
manganese and then delivery to the brain (Tjilve et al., 1999). However, this route of
delivery of manganese to the brain is not well clear in human. The primary objective of
this study is to determine the effects of subchronic exposure to Mn phosphate/sulfate
mixture on Mn tissues concentrations, and locomotor activity.
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2.3 Materials and Methods
2.3.1 Chemicats
The manganese phosphate/sulfate mixture, a fine crystalline powder which includes
Mn5(P04)2(P03(OH))24H20 hureaulite minerai form, and manganese (II) sulfate
monohydrate (MnSO4. I-120), were obtained from Alfa Aesar (Johnson Matthey
Company), and combined in a 50:50 ratio. Whereas manganese sulfate is relatively water
soluble, manganese phosphate is insoluble.
2.3.2 AnimaIs
One hundred and twenty, 6 week-old male Sprague-Dawley rats weighting 125-150 g
were purchased from Charles River Laboratories (St.Constant, Quebec, Canada) and
marked on the tail for identification purposes. Rats were acclimated for approximately 2
weeks in HEPA filtered air. Animais were given NIH-07 chow ad libitum when they
were not exposed. All experiments were undertaken with the consent ofthe animal ethics
committee of the University of Montreal, and were conducted in accordance with the
guidelines set out by the Canadian Council on Animal Care. Rats were individually
housed in a polycarbonate cage with stainless steel wire lids under constant conditions of
temperature and humidity, with 12:12 h day/night cycles. The subjects were randomly
divided into 4 groups with 30 animals in each group for two different periods. Body
weight and food and water consumption were measured weekly.
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2.3.3 Inhalation Exposure
A control group and three groups of 30 male Sprague-Dawley rats each were respectively
exposed to 3000, 300 and 30 jig/m3 manganese phosphate/sulfate mixture. Exposure was
conducted in two inhalation chambers with a total volume of 1 m3 each (Hazelton
Systems Company, Inc., Kalamazoo, MI) over 13 consecutive weeks, 5 days per week, 6
hr/day. The chamber received (HEPA) filtered air and was maintained at a constant
temperature (22-25 °C) and relative humidity (25-40%) throughout the study. Mn aerosol
was generated by a fluidized Bed Aerosol Generator (Model 3400, TSI Inc., $t. Paul,
MN) with a flow rate of 200-250 L/min. Stainless steel A$ME pressure tanks was used in
order to obtain fine particles.
Concentrations were verified continuously using a Dust Track (Model $520) aerosol
monitor. In both chambers, air samples were collected on a daily basis to monitor Mn
concentrations, using a sampling system consisting of Gilian pumps (Gilian Corp., West
Caldwell, NJ) with standard 3-piece cassettes and 37-mm diameter filters. The filters
were Teflon (manufactured for SKC Inc., Gelman Sciences, Ann Arbor, MI) 0.45 tm
pores. Pumps were used at a constant flow rate of 1.5 L/min. The flow rate was calibrated
each day with a Gilibrator (Gilian Corp., West Caldwell, NJ). The particle size
distribution of manganese phosphate! sulfate mixture was measured by using a six-stage
Marple Personal Cascade impactor (Series 290). Rats were individually housed during
the non-exposure period and were weighed weekly. Food and water were available ad
libitum when the rats were flot exposed.
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2.3.4 Locomotor Activity Assessment
four hours after the last Mn inhalation exposure, the rats were tested for motor activity.
A computerized Auto-Track System (Columbus instruments, Ohio, U.S.A.) was used to
measure locomotor activity for a period of 36 consecutive hours. This system is consisted
of a 15 by 15 inftared beam array with an interbeam distance of 2.4 cm along the X and
Y-axes. Data was collected every 0.1 second and the motor activity categorized as
distance traveled by rats and resting time. The system was installed in a quiet isolated
room with 12 h light / 12 h dark cycles.
2.3.5 Tissue Concentrations
Following locomotor activity assessment, rats were anesthetized in a glass-walled
container containing a pledget wet with metofane, an inhalation anesthetic. As soon as
the animals were anesthetized, they were sacrificed by exsanguinations and the following
tissues and organs weighed and analyzed: liver, lung, kidneys, testis, and one hemisphere
of the brain. (olfactory bulb, globus pallidus, caudate/putamen, frontal cortex, and
cerebellum). Blood samples were taken from the abdominal aorta for chemical and
biochemical analyses and determination of Mn concentrations.
2.3.6 Chemical Anatysis
Manganese concentrations in blood, food, water, and tissues were measured by fNAA
(Kennedy, 1990) using a flue nuclear reactor and an EG&G ORTEC (mode! DSPec)
digital gamma-ray spectrometer incorporating a high-resolution large-volume germanium
detector. The potential interference from fe was reduced by irradiating samples in a more
thermalized neutron spectrum, verified and corrected for blood.
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2.3.7 Biochemicat Profite
Blood samples were colÏected from the abdominal aorta of anesthetized rats. Blood serum
was obtained by centrifugation at 4°C for 15 minutes at 3000 g. The biochemical tests
were performed using standard techniques for glucose, urea nitrogen, serum creatinine,
bilirubin, transaminases (AST, ALT), and alkaline phosphatases (ALP).
2.3.8 Statisticat Anatysis
The Dunnet T3 test was used to compare among ail pair treatment groups for mean
concentrations of Mn in blood, kidney, liver, lung and testis. A simiiar analysis was
conducted for Mn concentrations in different regions of the brain (cerebellum, frontal
cortex, globus pallidus, caudate putamen, and oifactory bulb), motricity (distance
travelled and resting time), the ten serum biochemicai parameters, and body weight in
each of the four treatment groups. Homogeneity of variances for the treatment groups
was assessed using Levene’s test. All analyses were performed using SPSS statistical
software (version 11.0). The level of statisticai significance was set at P< 0.05 for the set
of 6 pairwise comparisons performed among the treatment groups using Dunett’s test.
Data are presented as group mean + standard deviation ($D).
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2.4 Resuits
2.4.1 Mn in the Inhalation Chamber
The average Mn concentrations obtained in this study were 34.8 ± 9.2, 290.8 + 76.8, and
2841 ± 529 tg/m3 for target concentrations of 30, 300, and 3000 tgIm3, respectively.
Based on the cascade impactor, 80% ofthe Mn phosphate /sulfate mixture particles in the
inhalation chamber were smaller than 1.55 J.im in aerodynamic diameter (Table 2.1).
Overail mean daily chamber temperatures ranged from 22-25 °C, and relative humidity
ranged from 25-40 %.
2.4.2 Tissue Concentrations
Tissue Mn concentrations are presented in Table 2. 2. Elevated lung manganese
concentrations were observed following exposure to 30, 300, and 3000 j.ig/m3 Mn. Mn
accumulation in the lung increasing in a dose-dependent manner. Increased testis
manganese concentrations were obseiwed following inhalation exposure at 300 and 3000
JIg/m3. Mn concentrations were elevated in blood and kidney only in rats exposed to the
highest level of Mn (3000 jig/m3). Liver manganese concentrations were unaffected at all
exposure levels.
Brain tissue manganese concentrations are shown in Table 2. 3. Manganese
concentrations in olfactory bulb increased in a dose-dependent manner. In addition, Mn
concentrations in the caudate putamen and globus pallidus were significantly increased
foïlowing exposure to 300 and 3000 tg/m3. Mn concentration in the cerebellum and
frontal cortex were elevated only in rats exposed to the highest level (3000 tg/m3). Mn
concentration ranged from 0.56-0.83 jig/g in cerebellum, 0.61-1.56 jig/g in the globus
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pallidus, 0.62-1.19 jig/g in the caudate putamen, 0.58-0.98 jig/g in the frontal cortex and
0.46-2.32 jig/g in the olfactory bulb. The highest average Mn concentrations in exposure
animais were observed in the oifactory bulb, and the lowest in the cerebeilum.
2.4.3 Body Weight
There was a significant reduction (p< 0.05) in body weight afier 13 weeks at the two
highest ievels of exposure (Fig.2.1). No significant difference in food intake was
observed among the different exposed groups. The average Mn concentrations in food
and water were 100 jig/g and 0.00002 jig/L, respectiveiy.
2.4.4 Locomotor Activity Assessment
Locomotor activity was assessed in term of the resting time (RI) ami distance traveled
(DT). Afier 36 hours, DT was significantiy increased afier exposure to 30 and 3000
Ig/m3 Mn, although there was no difference at 300 jig/m3. No significant difference in
RI was observed among the exposed groups (Table 2. 4).
2.4.5 Btood BiochemicatAnatysis
Table 2. 5 summarize the biochemical test resuits. Glucose, sodium, chlorate, urea, and
aikaline phosphate ieveis were significantly different in the animais exposed to highest
ievel ofthe Mn mixture.
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2.5 Discussion
Different MMT combustion products are produced depending on fuel combustion and
engine and catalytic converter thermodynamics. It is 110W well accepted that Mn is
emitted from the tailpipe primarily as a mixture of manganese phosphate and manganese
sulfate particles, with size ranging between 0.2 and 10 tm in aerodynamic diameters
(Zayed et al., 1999a). In fact, in the present study, the size of 100% ofthe particles was <
10 tm, while 87% were <3.5 jim.
Rats exposed to manganese in mixture form in our study had lower lung manganese
concentrations compared with levels observed in rats exposed to either manganese sulfate
(Dorman et al., 2001) or manganese phosphate (Vitarella et al., 2000, Normandin et al.,
2002). These results suggest that the mixture is more rapidly cleared from the lung
compared to other Mn compounds. The Mn phosphate/sulfate mixture is more water
soluble than Mn phosphate due to the water-solubility of Mn sulfate.
Accumulation of Mn phosphate/sulfate mixture in the lung is dose-dependent, which is
similar to what was reported previously by Vitarela et al (2000) and Normandin et al
(2002) afier exposure to Mn phosphate. This characteristic is important since the rate of
clearance from the lung is well known to influence metal deÏivery to the brain and other
organs. In a study by Rhoads and Sanders (1985), a number of metal compounds that
were more quickly cleared from the lungs were retained for longer periods at other sites
in the body, where they could potentially exert their toxic effects.
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A significant increase in biood manganese concentration for rats exposed to 3000 jig/m3
was observed. This was flot seen in rats exposed to either manganese phosphate
(Normandin et al., 2002) or manganese sulfate (Dorman et al., 2001). In comparison with
Mn phosphate, testis displayed aiso a different response after exposure to Mn mixture.
Groups exposed to 300 and 3000 jig/m3 had signfficantly higher testis manganese
concentrations compared to the control group. This finding is in agreement with the
resuits ofDorman et ai. (2001), where animals were exposed to high levels ofmanganese
sulfate. Exposure of laboratory animais to high leveis of manganese has been associated
with a variety of reproductive effects, inciuding evident histopathologic and biochemicai
changes in the somniferous tubule (Chandra, 1971; Imam and Chandra, 1975; Murthy et
al., 1980).
Studies conducted by Dorman and coiieagues have confirmed that delivery of inhaied
manganese to the brain is influenced by particle solubiiity. Moreover, animais exposed to
high ievei of the soluble sulfate form had significantly higher brain manganese
concentrations when compared with levels achieved following exposure to the insoiuble
tetroxide or phosphate forms (Dorman et ai., 2001). Our data indicate a significant
difference in brain manganese concentration in regions of interest such as the cerebellum,
frontal cortex, giobus paliidus, caudate putamen, and olfactory bulb in rats exposed to
highest level (3000 tg/m3) of Mn as compared to the reference group. Manganese
concentration in the olfactory buib was dose dependent. Also, Mn concentrations in the
globus pailidus and caudate putamen were higher than those reported by Vitarella (2000)
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following exposure to manganese phosphate (Normandin et al., 2002) and metallic
manganese (St-Pierre et al., 2001).
Absorbed manganese is transported to other organs via the iron-binding protein
transferrin, u2-macroglobulin, and albumin. Manganese readily crosses the blood-brain
barrier, and is largely distributed to the central nervous system (Aschner et al., 1999).
Following chronic exposure to high level of Mn in human and other primates, the metal
preferentially accumulates in the thalamic nuclei, substantia nigra, pallidum, and other
brain regions that also accumulate iron (Barbeau et al., 1976; Hill and $witzer, 1984). In
normal plasma concentrations, Mn enters in the brain mainly across the cerebral capillaries.
Since the Mn plasma concentration increases, entiy of Mn across the choroids plexus
becomes more important (Murphy et al., 1991). Intra-nasally administered Mn may
circumvent the blood-brain barrier and then pass directly into ffie central nervous system via
olfactory pathways (Tjalve et al., 1996), increasing its bioavailability to the brain (frumkin
and Solomon, 1997). A fraction of inhaled Mn is likely to reach cerebral target sites
before hepatic clearance (Roels et al., 1997).
Our data show that Mn concentrations in the olfactory bulb and other brain regions were
elevated. This is in agreement with Dorman et al (2001), who recently showed that an
inhaled metal could be delivered directly to the brain via the olfactory nerve. These data
indicate that following inhalation of manganese, manganese concentration achieved in
the olfactory bulb is significantly higher than those observed in either the striatum or
cerebellum, lending additional support to the direct olfactory transport theory. In the rat,
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the olfactory bulb comprises a relatively large section of the central nervous system, and
the nasal olfactory mucosa cover roughly 50% of the total nasal epithelium (Gross et al.,
1982). In human, these structures are proportionately smaller than in rats. It has been
suggested that if this route of brain delivery is operative in humans, then it miglit be less
important in humans than in rats (Dorman et al., 2001). Nevertheless, our results show
that Mn concentration in the olfactory bulb is at least 50 % higlier than ail other brain
tissues when rats are exposed to 3000 .ig/m3. Moreover, after such exposure, tissue
concentration for the olfactory bulb increased by 504%, in comparison to 255%, 191%,
169% and 148% for the globus pallidus, the caudate putamen, the frontal cortex and the
cerebellum respectively.
The analysis of the biochemical parameters revealed some significant differences in
sodium, glucose, chlorate, and urea in blood of rats exposed to highest level of the Mn
mixture (3000 ig/m3), leading to levels that can resuit in kidney failure (Murry et al.,
1995). In our study, rats exposed to 300 and 3000 ig/m3 also had higher levels ofaikaline
phosphate compared to the control group, which is suggestive of liver dysfunction
(Murry et al., 1995). However, modification ofAST, ALT, and total bilirubin, which are
indicative of liver malfunction, vas not apparent in this study.
Rats exposed to 300 and 3000 jig MnJm3 had exhibited a significant decrease in mean
body weight compared to the control group. This finding is quite different from other
resuits reported by our research group for metallic Mn (St-Pierre et al., 2001) and
manganese phosphate (Normandin et al., 2002). However, other studies have reported
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decreasing body weight following Mn exposure (Brenneman et al., 1999). There were no
significant differences among groups in total mean food consumption.
Our data indicate a significant effect of Mn on locomotor activity. We obseiwed that
exposure led to a significant increase in distance traveled for the groups exposed to 30
and 3000 ig/m3 as compared to the control group. However, there were no significant
differences in resting time. The increase in locomotor activity appeared to be associated
with increased Mn concentration in the brain. Similarly, in a study where rats were
exposed to 0.1 or 5.0 mg/ml of MnC12 in drinking water for $ months, a significant
increase in spontaneous motor activity was noted in the first month. Nevertheless, during
months 2 to 5 rats showed normal activity, with a significant decrease in motricity in
months 6 to 8 (Bonilla, 1984). Rats exposed to Mn orally were signfficantly more active
than controls in the empty open field, and also did flot show habituation (Calabresi et al.,
2001).
Brain Mn deposition is region-selective, being predominant in the basal ganglia, which is
involved in the control of movement and of sorne cognitive functions. Other than the
olfactory bulb, brain Mn deposition is mainly in the caudate putamen and globus pallidus,
which corresponds to the onset of neurological outcomes. The differences in spontaneous
motor activity cari be explained by the alterations in dopamine transmission in Mn
toxicity. Acute exposure to Mn is associated with an increase in dopamine
neurotransmission, which is also manifested as hyperactivity. Nevertheless, long-term
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exposure resuits in a 1055 of dopamine in the brain, and the neuronal celi damage could be
expressed as an increase in motor activity (Bonilla, 1984; Nachtman et al., 1986).
Does chronic exposure to the combustion products of the organomanganese compound
MMI used in gasoline may lead to toxic effects? The resuits of the present study
represent another step towards understanding the contribution of these emissions to
nervous system deficits.
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Table 2-1: Particles size distribution of Mn phosphate/sulfate mixture in the inhalation
chamber
Particle Size (tm) Percentage (%)
6.0 - 9.8 6.6 ± 2.7
3.5 - 6.0 6.2 ± 0.9
1.55—3.5 7.1±0.1
0.93 — 1.55 12.7 ± 2.8
0.52 — 0.93 40.8 ± 5.1
<0.52 17.3 ± 1.8
BFa 9.3 ± 6.8
aBF: backup filter
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Table 2-2: Mean manganese concentrations Qtg/g ± SD) in different tissues and blood
following subchronic (90 days) inhalation exposure to a manganese phosphate/sulfate
mixture
Exposure Concentration
Tissue
Control 30 jig/m3 300 ig/m3 3000 tg/m3
(n = 26) (n = 25) (n 29) (n = 29)
Blood 0.005±0.007 0.006±0.004 0.008±0.002 O.OI$±O.OO6C
Kidney 1.01±0.13 1.03±0.20 1.06±0.12 1.37±0.15
Liver 2.22±0.35 2.23±0.35 2.27±0.38 2.32±0.42
Lung 0.17±0.03 0.42±0.Oga 2. l5±O.5atJ 5.97±1 72abc
Testis 0.30±0.06 0.34±0.02 0.36±o.03a O.42±O.O2
a Significantly different from the control group (p<O.05)
b Significantly different from the 30 .tg/m3 group (p<O.05)
Significantly different from the 300 tg/m3 group (p<O.05)
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Table 2-3: Mean manganese concentrations (jig/g ± SD) in brain regions afler subchronic
(90 days) inhalation exposure to manganese phosphate/sulfate mixture
Exposure Concentration
Brain region
Control 30 jig/m3 300 tg/m3 3000 jig/m3
(n=26) (n25) (n =29) (n=29)
Cerebellum 0.56±0.15 0.57±0.04 0.60±0.04 O.$3±O.07h1x
Frontal Cortex 0.58±0.20 0.59±0.08 0.64±0.14 O.98±O.32
Globus Pallidus 0.61±0.15 0.63±0.04 O.81±O.O$’ 1.56±O.4O
Caudate Putamen 0.62 ±0.2 0.57±0.03 0.74±0.1 1b 1.19±0.1 1
Olfactory Bulb 0.46±0.07 0.61±0.05a l.32±O.l6 2.32±O.25
Significantly different from the control group (p<O.05)
b Significantly different from the 30 jig/m3 group (p<O.O5)
Significantly different from the 300 jg/m3 group (p<O.05)
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Table 2-4: Mean distance traveled and resting time over 36 hour period after subchronic
(90 days) inhalation exposure to manganese phosphate/sulfate mixture
Exposure concentration
Locomotor activity 3 3 3Control 30 pg/m 300 tg/m 3000 tg/m
(n=26) (n=25) (n29) (n=29)
Distance traveled (ni) 875±180 12o6±94’ 928±127 l39$±lO4
Restingtime(br) 31.9±9 31.7±5 31.9±8 32.4±6
Significantly different from the control group (p<O.O5)
b Significantly different from the 300 jgIm3 group (p<O.O5)
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Table 2-5: Biochemical parameters in semm following subchronic (90 days) inhalation
exposure to a manganese phosphate/sulfate mixture
Exposure Concentration
Biochemical Parameter 3 3 3Control 30 jig/m 300 pg/m 3000 tg/m
(n=26) (n=25) (n29) (n=29)
Glucose (mmol/L) 11.6±2.3 9.$±0.97a 10.5±1.7 9.s±1.7’
Creatinine (mol/L) 54.2±4.5 54.3±2.1 52.1±3 53±2.9
Sodium (mmol/L) 139.3±1.8 144.s±1.6a 143.1±3.1’ 142.5±2.2a
Potassium (mmol/L) 5.1±0.4 4.9±1.1 5.3±1.1 5.8±0.9
Chlorate (mmol/L) 100.9±2.1 104.6±1.7a l04.1±1.8’ 103 .2±1 4a
Bilirubin (jimol/L) 3.5±0.9 4.0±0.6 3.9±0.7 3.7±1.2
Urea (mmol/L) 5.6±0.7 6.3±0.6’ 5.7±O.6b 6.4±o.6a
AST(U/L)’ 77.8±21.2 88.4±18.5 70.5±17.3 72.9±17.2
ALT (U/L)2 43.3±8.2 53.8±15.5 48.6±7.3 5 1.8±15.5
Aikaline Phosphatase (VIL) 113.6±34.7 140.9±42 1so.1±49.4a l83.s±51.3’
1Asparate arninotransferase.
2AÏanine aminotransferase.
Signiflcantly different from the control group (p<O.O5)
b Significantly different from the 30 igIm3 group (p<O.05)
Significantty different from the 300 tgIm3 group (p<O.05)
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Figure 2-1: Mean body weight of rats following subchronic (90 days) inhalation
exposure to a manganese phosphate/suÏfate mixture
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3.1 Abstract
Methylcyclopentadienyl manganese tricarbonyl (MMI) replaced tetraethyl lead in
gasoline as an antiknock agent in 1976. The combustion of MMI leads to increased
manganese concentrations in the atmosphere, and represents one of the main sources of
human exposure to manganese. The nervous system is the major target of the toxicity of
manganese ami its compounds. The purpose of this study was to investigate the relative
neuropathology and neurotoxicity of a manganese phosphate/sulfate mixture in Sprague
Dawley male rats following subchronic (90 days) inhalation exposure. Three groups of
30 rats were exposed to 30, 300 and 3000 .tg/m3 of the manganese phosphate/sulfate
mixture in inhalation chambers for a period of 13 weeks, 5 days per week, 6 hours a day,
along with an unexposed control group of the same size. In each group, haif of the rats
had EMG electrodes implanted in the gastrocnemius muscle of the hind lamb to measure
tremor. At the end of exposure period, rats were sacrificed by exsanguinations and Mn
concentrations in different tissues (liver, lung, testis, and kidney), blood and brain
(caudate putamen, globus pallidus, olfactory bulb, frontal cortex, and cerebellum) were
detennined by neutron activation analysis. Neuropathology was assessed by counting
neuronal ceils in 2.5 mm2 grids in the globus pallidus, caudate putamen, and frontal
cortex. Neuronal ccli loss was significantly different in ail three areas of interest in rats in
the high dose group (3000 tg/m3). Neurobehavioral change was assessed by measuring
iocomotor activity and tremor among groups. Although there was no indication oftremor
in any of the exposed groups, locomotor activity was significantly increased at 3000
.ig/m3. Ihese resuits demonstrate that high levels of exposure to the manganese
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phosphate/sulfate mixture resuits in neuropathological changes in areas of the brain that
can lead to neurobehavioral effects.
Keywords: Manganese phosphate/sulfate mixture, inhalation exposure, neuropathology,
neurobehavioral effects
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3.2 Introduction
Manganese (Mn) is a necessary element for rnany biological functions such as enzyme
activation, and is a component of metalloenzymes. Mn deficiency in humans is
characterized by skeletal abnormalities and seizure while excessive exposure has been
associated with motor and psychological disturbances similar to Parkinson’s disease,
resulting in a condition called manganism (Pal et al., 1999). Manganism occurs mainly as
a resuit of chronic inhalation of high levels of Mn (Mena et al., 1967). Clinical symptoms
include the presence of generalized bradykinesia, rigidity, tremor and dystonia (Verity et
al., 1999). Manganism is caused by an increase of Mn in the globus pallidus, caudate
putamen, and substantia nigra regions of the brain. Less severe neurological symptoms
occurring as a resuit of chronic inhalation exposure to Mn include deficits in short-tenu
memory capacity, hand steadiness, reaction time and hand-eye coordination (Mergler et
al., 1994).
Occupational studies have revealed neurological symptoms following exposure to
airbome Mn at concentrations of 0.2 to 5 mg/m3 for periods exceeding 20 years (Crump
and Rousseau, 1999, Goreil et al., 1999). Alteration of motor effects following Mn
exposure has been attributed to abnormal basal ganglia function (Huang et al., 1998).
Neuropathological features of these symptoms include neuronal loss and
polymicrocaviation in the basal ganglia (Jog et al., 1995). Although the mechanism of
Mn neurotoxicity is not entirely clear, it has been suggested that its toxicity is associated
with oxidative stress, which may play an important role in neuronal degeneration (Hamai
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et al., 2004). Another hypothesis is that Mn may affect dopamine metabolism in the brain
(Montes et al., 2001).
Although chronic occupational exposure to Mn at relatively high levels has been shown
to cause manganism, littie is known about the potential adverse effects of long-term
lower-level exposures. The introduction of the anti-knock agent methylcyclopentadienyl
manganese tricarbonyl (MMI) in gasoline leads to increased Mn concentration in the
atmosphere. There is some evidence to suggest that inhalable Mn (<5 tm in diameter) is
present at higher ambient concentrations in areas with higher traffic density (Loranger
and Zayed, 1997, Boité et al., 2004). The presence of different Mn species resulting from
the combustion of MMT has raised the concems about Mn neurotoxicity, particularly in
chiidren, the elderly (Weiss and Rehul, 1994) and in people with chronic liver disease
(Malecki et al., 1999).
Ihe purpose of this study is to assess neuropathology and neurotoxicity of Mn
phosphate/sulfate mixture one of the combustion products of MMI in ambient air,
following subchronic inhalation exposure in rats. Neurotoxicity and neuropathology
effects were investigated by assessing locomotor activity, tremor, and counting neuronal
celis in critical brain areas.
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3.3 Materiais and Methods
3.3.1 Chemicais
The manganese phosphate/sulfate mixture is an amalgamation of
Mn5(P04)2(P03(OH))24H20 (hureaulite minerai form) and manganese (II) sulfate
monohydrate (MnSO4. H20) obtained from Alfa Aesar (Johnson Matthey Company), and
combined as 50 wt/50 wt. The chemistry of the mixture was described in a previous
publication (Beaupré et al., 2004). Interestingiy, Mn sulfate is relatively water soluble,
and Mn phosphate is insoluble. Ail chemicais used in surgery, including anesthetic
mixtures such as hypnorm-midazolan, buprenorphine (analgesic), and baytril
(antibacterial solution), were obtained from the veterinary facility of the Institute of
Animal Care and Use at the University ofMontreal.
3.3.2 Animais
Ail experiments were approved by the animal ethics committee of the University of
Montreal, and were carried out in accordance with the guidelines defined by the Canadian
Council on Animal Care. Six-week old male $prague-Dawley rats (n120) were
purchased from Charles River Laboratories (St.Constant, Quebec, Canada) and marked
on the tail for identification purposes. Rats were acclimated for approximately 2 weeks in
HEPA filtered air. Animais were given NIH-07 chow ad libitum when they were flot
exposed to Mn. Rats were individually housed in polycarbonate cages with stainless steel
wire iids under constant conditions of temperature and humidity, with 12:12 hr day/night
cycles. The animais were randomly divided into 4 groups with 30 animais in each group.
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In each group, haif of the rats were implanted with EMG electrodes. Body weight and
food and water consumption were measured weekly.
3.3.3 Inhalation Exposure
Three groups of 30 male Sprague-Dawley rats each were exposed to 3000, 300 and 30
manganese phosphate/sulfate mixture, respectively, along with an unexposed
control group of the same size. Exposure occuned in two inhalation chambers, each with
a total volume of 1 m3 (Hazelton Systems Company, Inc., Kalamazoo, MI), for 13
consecutive weeks, 5 days per week, 6 hr/day. Further details are given in Salehi et al.
(2003).
3.3.4 Electrode Implant Procedures
Haif of the animais in each group were surgically implanted with chronic EMO
electrodes in the gastrocnemius muscle in the lefi hind limb afier 10 weeks exposure.
Rats were anesthetized with a mixture of hypnorm-midazlan (0.27 ml/IOOg). A large
area of the back of the neck and lefi hind iimb were then shaved and sterilized with
alcohol, and an electrode comprised of 3 fluorocarbon-insulated stainless steel wires
attached to 3 strip header of a fiberglass mesh base implanted in that area (Gardiner et al.,
1986). An approximately 3 cm cutaneous cut was made beside the dorsal midiane in the
cervicothoracic section, and the fiberglass mesh base of electrode was located under the
skin in the cervicothoracic region. On the lefi leg, the gastrocnemius muscle was opened
and two of the tbree electrodes were inserted into the muscle. To prevent wire movement,
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the ends of the wires were capped with quick-drying epoxy. The third electrode was left
free under the skin to serve as a ground. At termination, opened skins were sutured and
stapled with an auto clip. The analgesic (0.05 mg/kg) and antibacterial solution were
administered subcutaneously immediately afier surgery aixd 24 hours later.
3.3.5 Oxotremorine Administration
Oxotremorine, a Parkinson mimetic agent, was administrated in rats to induce
gastrocnemius muscle tremor. Specifically, a 0.1 mg/kg dose of oxotremorine was
injected intraperitonealy into the two implanted EMG electrodes rats. Tremor was
observed five minutes after injection, and rapid muscle EMG activity was recorded.
3.3.6 Tremor Assessment
An assessment of tremor was conducted one hour afier the last exposure by recording
muscle EMG activity for approximately 5 minutes while the animais were resting in their
cages, walking on the floor, and standing on a vertical 39 cm metai screen grid. A header
coimector was attached to each rat’s electrode in order to transmit the EMG signals to an
EMG amplifier (Honeywell, Denver, CO). An oscilloscope (Hewlett Packard, model
1741A, Palo Alto, CA) was used to observe the amplified signais, which were recorded
on a stereo video cassette (A.R. Vetter, model $LV-585HF, Rebersburg, PA). The
recorded signais were converted to a power spectrum by using Fourier transform
program.
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3.3.7 Neuropathological Assessment
The frozen lefi hemisphere of the brain was sectioned in a cryostat and adjacent 20 tim
sections, 2.4-3.4 mm lateral according to the rat brain atlas of Paxinos and Watson
(1982), were mounted on gelatinized siides. Slides were fixed in a solution of 0.4 M
sodium cacodylate, 50% glutaraldehyde for one hour at 4°C. The siides were then placed
in a buffer solution of one part 0.4 M sodium cacodylate and three parts water ovemight
at 4°C. Siides were then stained with Cresyl violet, dehydrated serially in 70, 95, and
100% ethanol, cleared in Xylen, and coverglassed with Permount. Slides were evaluated
by light microscopy at a magnification of 40 x 10. In ail cases, sections were chosen to
ensure neuronal celI counts were carried out at the same brain level. Neuronal ceil counts
were obtained in the globus pallidus, frontal cortex, and caudate putamen in 2.5 mm2
grids.
3.3.8 Statistical Analysis
Pairwise comparisons among the four experirnental groups were performed using the
Dunnet T3 test. Homogeneity of variances among the treatment groups was assessed
using Levene’s test. Ail analyses were performed using SPSS statistical software (version
11.5). The level of statistical significance was set at P = 0.05 for the set of 6 pairwise
comparisons performed among the four treatment groups. Data are presented as group
means + standard deviation ($D).
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3.4 Resuits
3.4.1 Mn Concentrations in the Inhalation Chamber
Mean Mn concentrations were observed to be 34.8 ± 9.2, 290.8 ± 76.8, and 2841 ± 529
jig/m3 for the target concentrations of 30, 300, and 3000 igIm3 , respectively. About 80%
of the Mn phosphate/sulfate mixture particles in the inhalation chamber were smaller than
1.55 jim in aerodynamic diameter. The daily chamber temperatures ranged from 22 - 25
°C, and relative humidity ranged from 25 - 40 %.
3.4.2 Neuropathological Assessment
Neuropathological assessment was based on neuronal celi counts in the brain areas of
interest, including the giobus pallidus, frontal cortex, and caudate putamen. Neuronal ceil
counts were significantly decreased in the globus pallidus (5 1.23 ± 5.50) and caudate
putamen (78.92 + 5.07) in rats exposed to 3,000 ig/m3, in comparison with unexposed
controls (72.55 + 3.37 and 93.90 ± 2.46 respectively) (figure 3.1).
3.4.3 Tremor Assessment
Tremor was observed in rats within 5 minutes after injection of oxotrernorine. Figure 3.2
shows the frequency of the EMG signais for observed tremor. figure 3.3 shows a typical
EMG signal for an exposed animal. The mean percentage of the maximum power of the
EMG signal was calculated for visible tremor at frequencies between O to 50 Hz (Table 3.
1). More than 82 % of maximum power ofthe EMG signal was concentrated in the range
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o to 20 Hz. The mean percentage of maximum power of the EMG signal also was
calculated when the test animals were resting in the cage, walking on the floor, and
standing on a vertical grid. The maximum power of the EMG signal derived from
oxotremorine injected rats did flot correspond with that observed in rats treated with the
Mn phosphate/sulfate mixture. The analysis data of EMG signal are presented in the
tables 3.2, 3.3, and 3.4. The analysis of tremor signal caused by oxotremorine indicated
that 29% ofthe maximum power ofthe EMG signal was observed at frequencies between
O to 10 Hz, with 53% ofthe maximum power between 10 to 20 Hz. We did not observe a
similar percentage of maximum power between O to 20 Hz in Mn treated rats.
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3.5 Discussion
The extensive use of MMI in gasoline resulting in Mn emissions to the atmosphere
represents a significant source of human exposure to inorganic Mn in urban areas with
high traffic density (Zayed et al., 2001). Exposure to high concentrations of Mn for long
periods of time can lead to a classic syndrome known as manganism. Manganism is
characterized by a slow deterioration of neurological function that begins insidiously as
non-specific symptoms and subclinical neurological signs. Dysfunction of the basal
ganglia develops, characterized by alterations of gait, Ioss of balance, fine tremor, loss of
facial expressions, and speech disturbances. finally, a severe disabÏing Parkinson’s-like
clinical condition develops, characterized by muscle rigidity, a staggering fait, dysphasia,
and a course intention tremor (Rodier, 1955). Occupational studies revealed
neurobehavioral effects following chronic inhalation exposure to relatively low levels of
Mn, including impaired performance of tasks that require coordinated, sequential, and
altemating movements at a rapid speed (Mergler et al., 1994, Lucchini et al., 1999).
Few studies have assessed the neurotoxic effects associated with inhalation exposure to
low level of Mn, particularly Mn species related to MMI combustion. Our
neuropathological assessment revealed a significant decrease in the number of neuronal
ceils in the globus pallidus and caudate putamen at the highest level of exposure (3000
jig/m3). Ibis finding differs ftom previous reported by our research group for Mn
phosphate (Normandin et al., 2002). This difference may be explained by the higher Mn
brain concentrations following exposure to the Mn phosphate/sulfate mixture. In particular,
Mn concentrations in the caudate putamen (1.19 ± 0.11) and globus pallidus (1.56 ± 0.40)
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were significantly higher for the Mn phosphate/sulfate mixture (Salehi et al., 2003) in
comparison with data obtained with Mn phosphate (Normandin et al., 2002) in the
caudate putamen (1.06 + 0.14) and globus pallidus (1.25 + 0.23) and 0.86 ± 0.04 and 0.93
+ 0.06 respectively for metallic Mn (St-Pierre et al., 2001). Dorman et al. (2001) noted
that delivery of inhaled Mn to the brain is influenced by particle solubility. Exposure to
the soluble form of Mn compound may resuit in elevated brain concentrations, as
compared to the insoluble forrn (Dorman et al., 200f).
Our observation of higher Mn concentrations in gÏobus pallidus and caudate putamen and
reduced neuronal celi counts in these areas of the brain are consistent with the Ioss of
brain celis in patients with manganism (Nagatomo et al., 1999). The application of
magnetic resonance imaging (MRI) techniques to patients with manganism demonstrated
elevated Mn concentrations in the basal ganglia, particularly in the globus pallidus
(Nagatomo et al., 1999). Severely affected patients also develop progressive irreversible
loss of dopaminergic neurons in the globus pallidus and nigrostriatal pathway (Came et
al., 1994; Olanow, 2004).
Although the mechanism of Mn-induced neurological effects been studied for decades, it
is still flot fully understood. Several hypotheses have been advanced to explain the
relation between Mn exposure and the loss of neuronal ceils. The main portais of Mn
absorption in plasma are the gastrointestinal tract and the lung (Aschner et al., 1991).
Absorbed Mn exists as divaient and trivalent Mn in plasma (Scheumamer and Cherian
1985). Both forms may distribute to the central nervous system via the blood-brain and
the blood-cerebrospinal fluid barriers (Takeda, 2003). Mn may also circumvent the blood
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brain barrier, and pass directly into the central nervous system via olfactory pathways
(Tjilve et al., 1996, Frumkin and Solomon, 1997). Divalent Mn can be transported into
brain capillaiy endothelial calis and choroidal epithelial ceils via undefmed transporters. It
also appears that a large portion of divalent Mn exists in non-protein-bound as a free ion
(May et al., 1997). This free ion can be transported into the brain via calcium channels
(Narita et al., 1990) or Na and Ca exchanger (Frame et al., 1991). Trivalent Mn is able to
bound to transferin and be transported across the brain barrier via the receptor-mediated
endocytosis (Takeda et al., 2003). When Mn enters in the brain, it can bind to Mn
metalloproteins such as glutamine, which are synthesized in astrocytes.
Several studies have documented that increased Mn concentrations in the brain may alter
the level and metabolism of neurotransmitters such as dopamine, y-aminobutyric acid,
and glutamate (Erikson et al., 2003). Glutamate is the most common excitatory
neurotransmitter, and 7-aminobutyric acid is the most abundant inhibitory
neurotransmitter. These neurotransmitters are responsible for the control of motor
behaviors (Carlsson, 1990). Astrocytes may play a key role in Mn-induced neurological
effects in the brain (Hazell, 2002). HazeIl (2002) suggested that the involvement of
energy metabolism of mitochondria in astrocytes could cause the Mn-induced
neuropathology. Other studies have suggested that glutamate-mediated excitotoxicty
may be responsible for the neurological effects of Mn in the brain (Brouillet et al., 1993).
Hazeil and Norenberg (1997) have studied the oxidant capacity of Mn in reduction of
glutamate uptake. In a further study, they found that increased Mn concentrations in the
basal ganglia could lead to oxidative damage in astrocytes, with a concomitant reduction
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of glutamate uptake (Hazeil and Norenberg, 1998). Mn accumulation in the brain may
therefore cause major changes in astrocytes, including: reduction of glutamate uptake,
reduction in mitochondrial energy metabolism in astrocytes, increased excitoxicity, and
proliferation of astrocytes. These effects may play a key i-ole in impaired astrocytic
neuronal interaction, which resulting in neuronal ceil death (Hazeil, 2002).
Our previous assessment of locomotor activity showed an increase in motor activity for
rats exposed to higher concentration of Mn phosphate/sulfate mixture (Salehi et al.,
2003). The differences in spontaneous motor activity may be explained by the alterations
in dopamine transmission associated with Mn toxicity. Acute exposure to Mn is
associated with an increase in dopamine neurotransmission, which is manifested as
hyperactivity. Nevertheless, long-term exposure to Mn resuits in a loss of dopamine in
the brain, and the concomitant neuronal celi damage could be expressed as an increase in
motor activity (Nachtman et al., 1986; Bonilla, 1984). Therefore, neuronal loss can be
related to neurobehavioral changes, including motor function, and alterations in complex
cognitive functions (Vettori et al., 1999).
The neurophatological changes following exposure to the Mn phosphate/sulfate mixture
is inconsistent with previous resuits for Mn phosphate reported by our research group
(Normandin et al., 2002). This difference can be explained by the hypothesis that
astrocytic neurotoxicity following Mn exposure is related to the particular Mn species
involved and their solubility (Erikson et al., 2003).
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Tremor was assessed by electromyography (EMG) examination for 5 minutes on the last
day of exposure by recording muscle EMG activity. At the beginning of the study, two
implanted EMG electrodes rats were injected with oxotremorine and muscle EMO
activity measured. Oxotremorine is an active metabolite of a cholinergic drug, which
leads to tremor in rats with maximum frequency of 8-9 Hz (Siater and Dickinson, 1982).
Tremor as resuit of oxotremorine injection appears in the form of a tremor involving the
head and ail limbs, similar to resting tremor in Parkinson’s disease (Wilms et ai., 1999).
The maximum power of the EMG signal for oxotremorine injected rats was observed at
13.8 Hz, a finding close to that reported previously by other investigators in our research
group (Normandin et aI., 2002). This finding is also similar to the maximum power of the
tremor signal caused by oxotremorin in rats observed at frequencies between 5 and 12 Hz
(Nickei et al., 1997).
The anaiysis of tremor signai caused by oxotremorine indicated that 29% of the
maximum power of the EMG signal was observed at frequencies between O to 10 Hz,
with 53% ofthe maximum power between 10 to 20 Hz. Consequentiy, more then $2 % of
maximum power of the EMG signais is found at frequencies between O to 20 Hz. Our
data did not show a similar result of maximum power between O to 20 Hz in Mn treated
rats.
In generai, tremor caused by Mn is iess common at lower levels of exposure and, when
present, il tends to be posturai or kinetic rather than resting as seen in Parkinson disease
(Huang et al., 1993). Resting tremor in Parkinson disease is characterized with
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degeneration of dopamine neurons in the substantial nigra (Hughes et al., 1992). In
contrast, Mn-induced tremor is described by damage to the palladium and striatum
(Wenning et al., 2000). An occupational study also indicated that workers exposed to
more than 27 mg!m3 of ambient Mn exhibit postural but flot resting tremor (Huang et al.,
199$). The tremor signal induced by Mn in humans occurs at ftequencies less than 10 Hz
(Sadek et al., 2003).
b date, few studies have investigated tremor as a resuit of Mn exposure in animal
models; most of these studies have found no evidence of tremor following exposure to
Mn (Normandin et al., 2002; Pearce et al., 1995; Olanow et al., 1996). However, adult
rhesus monkeys have shown other neurological syndromes following intravenous
injection of Mn chloride, including facial grimacing, bradykinesia, and rigidity, but not
tremor (Olanow, 2004). The only animal study in which active tremor was observed
involved monkeys subjected to 7 intravenous injections of 10 mg/kg of Mn chloride
(Newland and Weiss, 1992). In general, the histopathological characteristies in resting
tremor from Parkinson’s disease and tremor caused by Mn are completely different.
Further studies are needed to provide more information on the clinical, pharmacological,
and pathological features of Mn tremor and Parkinson tremor.
More research is also needed to clarify the toxicity of inorganic Mn, which is emitted to
the atmosphere as consequence of the increased usage of MMI in gasoline. The Mn
phosphate/sulfate mixture considered in this paper is one of the main combustion
products of MMT, which represents one of the first toxicological studies on this mixture.
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Our resuits raise concems about the potential for Mn neurotoxicity with increasing
exposure due to higher traffic density. Subpopulations such as elderly in the early stages
of neurodegenerative disease (Gwiazda et al., 2002) and people with liver disease (e.g.,
cirrhosis) (Montes et aÏ., 2001) may be particularly susceptible to Mn neurotoxicity.
Definition of the dose-response relationship for the manganese phosphate/sulfate mixture
will be useful in establishing reference doses and human exposure guidelines for airbome
manganese.
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Table 3-1: Mean percentage ofthe maximum power ofEMG signais in oxotremorine
injected rats
Frequency (Hz) Percentage of maximum power of EMG signal
0-10 29.1
10-20 53.6
20-30 4.8
30-40 8.0
40-50 4.4
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Table 3-2: Mean percentage of maximum power ofEMG signal for rats in the walking
position at different levels of Mn exposure
frequency (Hz) Percentage of maximum power of EMG signal
Control 30 tg/m3 300 tg/m3 3000 ig/m3
(n11) (n=10) (nl2) (11=11)
0-10 11.65 ± 4.81 10.59 ± 3.12 11.81 ± 4.23 12.59 + 4.11
10-20 8.93+3.77 9.44+3.03 7.98±3.21 11.67+3.55
20-30 15.42+3.59 15.88±3.15 16.02±3.62 17.22+3.19
30-40 26.50±5.11 28.22±4.91 24.98±6.13 28.41±5.93
40-50 37.5±7.98 35.87±7.83 39.21 ± 7.8$ 30.11 ± 7.54
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Table 3-3: Mean percentage of maximum power ofEMG signal in rats in the resting
position at different levels of Mn exposure
Frequency (Hz) Percentage of maximum power ofEMG signal
Control 30 jig/m3 300 1g/m3 3000 tg/m3
(n11) (n10) (n12) (n11)
0-10 9.14±4.88 8.26±3.12 9.21±3.43 11.58± 5.31
10-20 8.03 ± 3.27 7.44 ± 3.03 7.28 ± 3.51 8.67 ± 3.45
20-30 19.42±8.59 18.98±3.12 19.92±5.62 19.21±3.17
30-40 29.50 ± 5.52 31.22 ± 6.21 34.15 ± 7.13 36.41 ± 8.53
40-50 33.91 ± 7.98 34.1 + 7.53 29.44 + 7.68 24.13 ± 7.44
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Table 3-4: Mean percentage of maximum power ofEMG signal in rats when standing on
a vertical grid for different levels of Mn exposure
Frequency (Hz) Percentage of maximum power of EMG signal
Control 30 tg/m3 300 tg/m3 3000 jig/m3
(n11) (nlO) (n12) (n11)
0-10 21.65 ± 8.29 14.53 ± 5.18 11.88 ± 5.31 14.59 ± 6.22
10-20 10.94 ± 4.77 8.49 ± 3.53 7.02 ± 3.40 8.70 ± 3.45
20-30 11.52 ± 3.19 12.08 ± 3.90 11.92 ± 4.39 13.82 ± 3.17
30-40 23.04 + 9.81 25.19 ± 8.91 25.93 ± 7.62 24.91 ± 6.37
40-50 32.85±9.88 39.71±9.87 43.19±9.18 37.98±8.53
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figure 3-1: Mean neuronal celi counts in the globus pallidus, caudate putamen, and
frontal cortex of rats afier subcbronic inhalation exposure of Mn (± SD)
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Figure 3-2: Tremor signais in oxotrernorine injected rats. A shows a pattern offtequency
(Hz) ofEMG signais per time (ms). B represents rectified signais. C shows the power
(volt) of frequency of signais.
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Figure 3-3: Typicai EMG signais in rats exposed to Mn. A shows a pattern of frequency
(Hz) of EMG signais per time (ms). B represents rectified signais. C shows the power
(volt) of frequency of signais.
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Discussion
The rate of Mn clearance from the lung has been recognized to influence the metal
delivery to the brain and other organs. In a study by Rhoads and Sanders (1985), a
number of metal compounds that were more quickly cleared from the lungs were retained
for longer periods at other sites in the body, where they could potentiaÏly exert their toxic
effects. In our study the rats that were exposed to a Mn mixture had lower lung
manganese concentrations compared with the levels observed in rats exposed to either
Mn sulfate (Dorman et al., 2001) or Mn phosphate (Vitarella et al., 2000, Normandin et
al., 2002). In addition, blood Mn concentration was significantly increased at the highest
level ofexposure (3000 jig/m3) that was flot seen in rats exposed to either Mn phosphate
(Normandin et al., 2002) or Mn sulfate (Dorman et al., 2001). These variations of Mn
concentrations may likely illustrate that the Mn mixture is more rapidly cleared from the
lung and readily absorbed into the blood as compared with other individual Mn
compounds.
Groups exposed to 300 and 3000 jig/m3 had significantly higher testis Mn concentrations
compared to the control group. This finding is similar to the results of Dorman et al.
(2001), where animais were exposed to high levels of Mn sulfate. In contrast, testis
displayed a different response afier exposure to Mn phosphate. Rats exposed to 300 and
3000 tg/m3 Mn had exhibited a significant decrease in mean body weight compared to
the control group. The analysis of the biochemical parameters revealed some significant
differences in sodium, gtucose, chlorate, and urea in blood of rats exposed to the highest
level of the Mn mixture (3000 tg/m3), leading to levels that can resuit in kidney failure
9$
(Murry et al., 1995). In our study, rats exposed to 300 and 3000 jig/m3 also had higher
levels of aikaline phosphate compared to the control group, which is an indication of liver
dysfunction (Murry et al., 1995). These findings are quite different from the resuits that
have been reported by our research group for metallic Mn (St-Pierre et al., 2001) and Mn
phosphate (Normandin et al., 2002). In the other hand, exposure to Mn phosphate/sulfate
mixtures can be possibly more associated with systemic and reproductive adverse effects.
Dorman and colleagues have confirmed that delivery of inhaled Mn to the brain is
influenced by particle solubility. Moreover, animais exposed to high level of the soluble
sulfate form had significantiy higher brain Mn concentrations compared with the
insoluble tetroxide or phosphate forms (Dorman et al., 2001). Our data indicate a
significant difference in brain Mn concentration in globus pallidus, caudate putamen, and
olfactory buib in rats exposed to the highest level (3000 tg/m3). Mn concentrations in the
globus paliidus and caudate putamen were higher than those reported by Vitarella (2000)
following exposure to Mn phosphate (Normandin et al., 2002) and metallic manganese
($t-Pierre et al., 2001). Hence, higher brain Mn accumulation can be corresponded to the
either higher solubility or more effectiveness of the mixture compared to the individual
compounds.
Our data show that the Mn concentrations in the olfactory bulb were at least 50 % higher
than other brain regions at the highest level of exposure (3000 jig/m3). Mn concentration
in the olfactory bulb increased by 504 %, in comparison to 255 %, 191 %, 169 % and 148
% for the globus pallidus, caudate putamen, frontal cortex, and the cerebellum,
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respectively. This is in agreement with Dorman et al. (2001), who recently showed that an
inhaled metal could be delivered directly to the brain via the olfactory nerve. In the rat,
the olfactory bulb represents a relatively large section of the central nervous system, and
the nasal olfactory mucosa cover roughly 50% ofthe total nasal epithelium (Gross et al.,
1982). This region of the brain is relatively smaller in human, therefore Mn delivery to
the human brain via this region might be less significant (Dorman et al., 2001).
The locomotor activity assessment showed a significant increase in distance traveled for
the groups exposed to 30 and 3000 ig/m3 compared with the control group. The
increased activity in rats exposed to 30 1g/m3 did not seem to be accurate, because during
the evaluation period there was a construction activity at upper floor that made too ;nuch
noise and vibration. Therefore, the increased activity may flot be accounted as a resuit of
Mn exposure. There were also no significant differences in resting time among rats.
The increase in locomotor activity appears to be associated with increased Mn
concentration in the brain. Since brain Mn deposition is region-selective, largely in the
caudate putamen and globus pallidus, corresponding to the onset of neurological
outcomes. In this study, Mn concentrations in the caudate putamen and globus pallidus were
significantly higher for the Mn phosphate/sulfate mixture (Salehi et al., 2003) in
comparison with the data obtained with Mn phosphate (Normandin et al., 2002) and the
metallic Mn (St-Pierre et al., 2001).
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Similarly, the neuropathological assessment revealed a significant decrease in the number
of neuronal celis in the globus pallidus and caudate putamen at the highest level of
exposure (3000 tg/m3). Our resuits are different from previously reported data by ouï
research group for Mn phosphate (Normandin et al., 2002).
It lias been suggested that Mn accumulation in the brain may cause major changes in
astrocytes, including reduction of glutamate uptake, reduction in mitochondrial energy
metabolism in astrocytes, increased excitoxicity, and proliferation of astrocytes. These
effects may play a key role in impaired astrocytic- neuronal interaction, which resulting
in neuronal celis death (Hazell, 2002). Consequently, the neuronal ceils loss can be
associated to the neurobehavioral changes including locomotor activity.
Our observation of higher Mn concentrations in globus pallidus and caudate putamen and
reduced neuronal ce!! counts in these areas of the brain are consistent with the loss of
brain ceils in patients with manganism (Nagatomo et al., 1999). The neurophatological
changes following exposure to the Mn phosphate/sulfate mixture is inconsistent with
previous resuits for Mn phosphate reported by our research group (Normandin et al.,
2002). This difference can be explained by the hypothesis that astrocytic neurotoxicity
following Mn exposure is related to the particular Mn species involved and their
solubility (Erikson et al., 2003).
Tremor as a result of oxotremorine injection appears in the form of a tremor involving the
head and ail limbs, similar to resting tremor in Parkinson’s disease (Wilms et al., 1999).
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In this study, the maximum power of the EMG signais foiiowing oxotremorine injection
was observed at the frequency of 13.8 Hz, which is close to the data reported previousiy
by other investigators in our research group (Normandin et ai., 2002). This finding is also
sirnilar to the maximum power of the tremor signais caused by oxotremorine in rats,
which has been observed at the frequencies between 5 and 12 Hz by Nickel et al. (1997).
The analysis of tremor signais caused by oxotremorine indicated that more then $2 % of
maximum power of the EMG signals was found at frequencies between 0 to 20 Hz. Our
data did not show a simiiar result of maximum power between O to 20 Hz in Mn exposed
rats.
The type of tremor caused by Mn tends to be posturai or kinetic rather than resting as
seen in Parkinson’s disease (Huang et ai., 1993). Resting tremor in Parkinson’s disease is
characterized with degeneration of dopamine neurons in the substantiai nigra (Hughes et
al., 1992). In contrast, Mn-induced tremor is described by damage to the basal ganglia
(Wenning et al., 2000). An occupationai study also indicated that workers exposed to
more than 27 mg/m3 of ambient Mn exhibited postural but flot resting tremor (Huang et
ai., 1998). The tremor signai induced by Mn in humans occurs at frequencies iess than 10
Hz ($adek et al., 2003).
To date, few studies have investigated tremor as a resuit of Mn exposure in animal
models. Most of these studies have found no evidence of tremor foilowing exposure to
Mn (Pearce et ai., 1995; Oianow et ai., 1996; Normandin et al., 2002). The oniy animai
study in which active tremor was observed involved monkeys subjected to 7 intravenous
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injections of 10 mg/kg of Mn chioride (Newiand and Weiss, 1992). Further weii design
animais studies are needed to provide more information on pathologicai, and clinicai
features of Mn tremor.
Overali, one of the limitations in this study was the lack of a very constant Mn
concentration during exposure period. This inconsistency can be caused by variation in
temperature and humidity in the inhaiation chamber that in tum has some effects on
particles generator. However, Mn concentrations obtained in this study were 34.8 ± 9.2,
290.8 + 76.8, and 2841 ± 529 jig/m3 for target concentrations of 30, 300, and 3000
ig/m3, respectiveiy. Another limitation in this study was the use of the young maie rats
instead of femaie or oid rats. One of the goals of this study was to investigate the
neurobioiogical and neurobehavioral aiteration due to Mn exposure, which could be
different in relation to the gender and age.
finally, to extend the resuits obtained in this study to human and characterize the
potentiai heaith risks following inhaiation exposure to Mn phosphate/sulfate mixture,
extrapolation can be made using the traditional approach. According to our data, the
lowest observable adverse effect ievel (increase in locomotor activity) is 30 jig/m3. This
would correspond to 3 1gIkg-day (30 jig/m3 x 0.22 m3/day x 6 h124 h /0.55 kg). To
caicuiate the dose, the following assumptions were made: ta) the rats inhaled 0.22 m3/day
of air and (b) the average body weight was 0.55 kg (Calabrese et al., 1991).
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The human-equivalent LOAEL (LOAEL1-wc) would be 10.5 ig/m3 (3 tg/kg-day x 70 kg!
20 m3!day). For this calculation a breathing rate of 20 m3/day and the average body
weight of 70 kg were assumed. Human reference concentration can be calculated by
dividing the LOAELHEC by uncertainty factors (UF) for subchronic to chronic
extrapolation (=10), animal to human extrapolation (10), and LOAEL to NOAEL
extrapolation (10). Therefore, RfC can be derived as 0.01 ig/m3 (RfC = LOAEL/Uf;
RfC = 10.5 jig/m3!1000) that is different from RfC established by U.S. EPA (1996).
However, the U.S. EPA RfC has been established for total Mn without any consideration
of Mn species. In fact, the results obtained with Mn phosphate by our research group,
conducted with the sarne animal model (Normandin et al., 2002), showed that the level of
3000 jig/m3 should be considered as LOAEL and 1.05 jig/m3 can be derived as RfC from
exposure to Mn phosphate (3000 g/m3 x 0.22 m3/day x 6 h124h / 0.55 kg = 300 ig/kg
day; 300 tg/kg-day x 70 kg! 20 m3/day = 1050/1000). Thus, the difference between Mn
phosphate and Mn phosphate/sulfate mixture shows the essential role of chemical form in
term oftoxicity assessment.
Additional consideration ofthe Mn uptake by other routes and sources would be needed
to refine the current estimates ofRfC. This is particularly relevant because their relative
importance might be different between animals and humans. In this context, contribution
of food and water to the background level of Mn in the body, dermal exposure as well as
ingestion by rats of skin-borne Mn (due to self-cleaning process) might be important. A
104
comprehensive evaluation ofthese processes in rats and humans should lead to the
refinement of the current estimation of the RfC for Mn.
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Conclusion
The Mn exposure has been an important issue in the last decades as a resuit of increased
usage of MMT in gasoline. The present study is unique in that it is the first study to
investigate the neurotoxic effects of Mn phosphate/sulfate mixture in rats. The resuits of
this study indicate that exposure to this mixture ieads to the onset of neuropathological
changes in particular areas of the brain and causes some neurobehaviorai differences
among the rats. These changes are exclusive for this mixture and have flot been seen with
other Mn species used in our researcli group. Therefore, the resuits of this study imply
that one should consider ail different Mn species for assessing the potential heaith risk
associated with the use of MMT in gasoline.
Our resuits raise concems about the potentiai for Mn neurotoxicity with increasing
exposure due to higher traffic density. Subpopuiations such as elderly in the early stages
of neurodegenerative disease and people with liver disease (e.g., cirrhosis) may be
particuiarly susceptible to Mn neurotoxicity. Further studies are needed to investigate the
neurotoxicity effect of Mn phosphate/sulfate mixture in female, young, and old animais
to improve our ability to establish a RfC to adequately prevent potential risk of Mn
exposure in generai popuiation.
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The use of methylcyclopentadienyl manganese tricarbonyl (MMT) in unleaded gasoline bas
given rise to numerous debates on tise potential public health risk associated with man
ganese emissions. In fact, combustion products are mainly Mn phosphate, Mn sulfate, and Mn
phosphate/sulfate mixture. Our research group did several inhalation studies in order to assess
the toxicity of each Mn species. The objective of this study is to determine the physical and the
chemical characteristics of a mixture of Mn phosphate/sulfate used in one of these inhalation
toxicology studies. First, the mixture was analyzed by X-ray diffraction in order to obtain tise
specific peak of Mn phosphate and Mn sulfate. These peaks were used as reference. Second,
samples of the mixture were collected un filters in the inhalation chamber at a concentration
level of 3000 jcg/m3. They were analyzed by scanning electron microscopy (SEM), analytical
transmission electron microscopy (ATEM), and x-ray energy-dispersive spectrometry (EDS) to
show their size, morphology, and chemical composition. Resuits indicate that 33% of the parti
des were found 10 be agglomerated, while free particles accounted for 44% for Mn phosphate
and 23% for Mn sulfate.
in July 1998 so that manganese-based fuel additives were flot
inc]udcd in the restriction (Zayed et al., 1999). Neverthcless,
the existing scientific knowledge related to the use of MMT
in gasoline has flot addressed the specific question of health
risk related to environmental chronic exposure. The magnitude
of the risk due to Mn emitted from the combustion of MMT
remains uncenain (Zayed, 2001).
Several studies have been donc in different occupational en
vironments that have shown that exposure to high atmospheric
Mn concentrations may have significant effects on human heatth
(U.S. EPA, 1997). Other studies have shown a relationship be
tween Mn exposure and neurological disorders (Mergier et al.,
______
1994; Roels et al., 1987; Wennberg et al., 1992), such as those
similar to Parkinson’s disease (Barbeau, 1984; Zayed et al.,
1990). However, the extrapolation of these resutts to chronic
exposure at low concentrations of Mn remains difficuit. Expo-
sure of the general population isa concem because Mn exposure
from MMT would occur over the course of a lifetime, rather
than during one’s working years (Lyznicki et al., 1999). If ad
verse effects do occur, it is likely that they will be subtie and
difficult to detect (Zayed, 2001; US. EPA, 1997). This is why
Taylor&Francis
• healthsciences
The inethylcyctopentadienyl manganese tricarbonyl (MMT:
C9H7MnO3) is an organic form of manganese. MMT is a fuel
additive developed in the 1950s to increase the octane level of
gasoline and to improve the antiknock properties of the fuel
(Lynam et al., 1990). It was introduced in Canada in 1976 and
ils use has increased since it completely replaced tetraethyl tead
in gasoline in the 1990s (Royal Society of Canada, 1986). In
1997, a law (C-29) was adopted by the federal govemment of
Canada, to ban both the interprovincial trade and the importa
tion for commercial purposes of manganese-based substances,
including MMT. However, the govemment reworded this law
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inhalation toxicology studies are needed with respect to the
different Mn species emitted from automobiles using MMT.
A few years ago, a preliminary car exhaust study (Ardeleanu
et al., 1999) provided qualitative data on the elementaiy compo
sition of particles collected from a tailpipe. It showed that most
ofthe particles consisted of Mn-O with phosphorus (P) and sul
fur (S) and, in some cases, also contained other elements such
as alurninum (AI), chromium (Cr), or iron (fe). More recently,
the physical and the chemical characteristics of the Mn com
pounds emitted from vehicles using gasoline-containing MMT
were detcrmined (Zayed et al., 1999). Particles emitted from
the taitpipe were trapped and characterized by scanning dcc
troll microscopy (SEM) and x-ray energy-dispersive spectrom
etry (EDS) and by analytical transmission electron microscopy
(ATEM). Resuits leU to the conclusion that Mn is cmitted from
the tailpipe primarily as a mixture of Mn phosphate and Mn
sulfate with sizes ranging between 0.2 and 10 /Im. On average,
more than 99% of the partictes were in the respirable fraction
(<5 ftm) and 86% wcre less than I tm in size. These results
are in agreement with those of Ressler et al. (2000) obtained by
x-ray absorption near-edge structure (XANES) spectroscopy.
They showed that the chemical forms of Mn-containing par
ticulates emitted from MMT-added gasoline engines are Mn
tetraoxide (Mn3 04), Mn sulfate (MnSO4.H2O), and a divalent
Mn phosphate (Mn5(PO4 )2 [P03(OH)j2 .4H70).
Three subchronic inhalation studies were undertaken by our
research group using an animal model in order to assess the
toxicity of cach of the three major Mn species emitted from
MMT combustion, namely. Mn phosphate, Mn sulfate, and Mn
phosphate/sulfate mixture (Salehi et al., 2003; Normandin et al.,
in press; Normandin et al., 2002). One of the critical issues
rclated to this last species is the percentage of Mn phosphate
and Mn sulfate obtained in the inhalation chamber. The aim of
this study is to verify the proportion of each of them.
METHODS
A 50/50 mixture was obtained by weighting the same quan
tity of Mn phosphate (hureaulite: [Mn5(P04)2(P03(OH))2•
4H2 O]) and Mn sulfate monohydrate (MnSO4.H2O) and then
mixing automatically during 24 h. These two Mn species were
obtained from Alfa Aesar (a Johnson Matthey Cornpany, Ward
Hill, MA).
One sample of each substance was collected and analyzed
by x-ray diffraction in order to obtain the specific peaks of each
substance. These peaks were used as reference.
Sampling
The inhalation chamber isa rectangular stainless-stecl cham
ber (131 cm long, 65 cm wide, and 125 cm deep) with a total
volume of 1 m3 (Hazelton Company, Inc., Kalamazoo, MI).
Air entcring the chamber was filtcred through a HEPA flUer.
The Mn aerosol particles were supplied to the chamber using a
fluidized-bed aerosol generator (TSI, Inc., St.-Paul, MN). Be
fore entering the chamber, Mn aerosol particles were dclivered
through a stainless-steel ASME pressure tank (Mc Master-Carr,
NJ) for the settling of larger Mn aerosol particles. The concen
tration in the chamber was monitored continuously using a Dust
Track (TSI, Inc., St.-Paul, MN) aerosol monitor. five samples
of the mixture were also collected in the inhalation chamber at a
concentration level of 3000 tlg/m3 using a Gilian pump (Gilian
Corp., Caldwell, NJ) with a standard 3-piece cassette and 37-
mm-diameter Teflon filters (SKC, Inc., Eightyfour, PA) with
0.45 im pore size. The pumps were calibrated at 1.5 L/min
with a Gilibrator (Gilian Corp., Caldwell, NJ), and sampling
lastcd over 6 h/day during 5 consecutive days (one filter per
day). b establish the particle size of the particles and to com
pare the results with the size of the Mn phosphate and the Mn
sulfate particles measured in other studies, air samples were
collected using a six-stage Marpel personal cascade impactor.
Scanning Electron Microscopy and X-Ray Energy
Dispersive Spectrometry
Residual particles on filters were observed and analyzed by
scanning etectron microscopy (SEM, Jeol 840) using secondary
electron images (SEl). The chemical composition of the parti
des was determined with an x-ray energy-dispersive spectrom
etry (EDS) detector coupled to the SEM and operated in the
windowless mode, allowing the detection of light elements such
as carbon (C) and oxygen (0) as we)l as alI the heavier elements.
The working distance used vas optimal for x-ray detection
(39 mm). The acquisition time used was long enough to allow
a clear differentiation between the two kinds of particles that
were present on the filters. For a particle to be considered as a
phosphate or a sulfate, the sulfur or phosphorus peaks needed
to be statistically significant. To achieve this, the Rose criterion
was used, which states that the change in signal (P or S peaks)
has to exceed the background noise by a factor of 5 (Goldstein
et al., 1992). b avoid charging of the sample by the incident
electron beam and a possible destruction of the filters during
the analysis, a thin layer (‘l5 nm) of a conductive coating of
carbon was deposited onto the surface of the filters.
The particles of size down to about 0.5 m were analyzed
using SEM; the smaller particles could not be analyzed in the
SEM because of the lack of resolution and the small number of
x-ray counts originating from such small particles.
Analytical Transmission Electron Microscopy
Analytical transmission electron microscopy (ATEM) was
used in order to analyze particles smaller than 0.5 11m, which
could not be analyzed in the SEM. A Philips 300-kv microscope
(moUd CM3O) was used for this purpose. To prepare samples
for ATEM, the filters were soaked in methanol and ultrasonic
agitation was used to release the particles from the filters. Three
millimeter Cu grids covered with a Formvar thin foil and a con
ductive coating of carbon were used to retrieve the particles
from the methanol solution and employed as ATEM samples.
The chemical composition was Uetermined using an EDS x-ray
system attached to the microscope, similar to the one used in
CHARACTERIZATI0N 0F A Mn PHOSPHATE/SULFATE MIXTURE 233
SEM. Since the resolution of the ATEM is much higher than
that of SEM and because the EDS detector is much closerto the
sample, it was possible to precisely analyze the very small par
ticles. For the statistic validation of the data, the same criterion
was used as for the SEM anatysis (Rose criterion).
X-Ray Diffraction
A Philips X’pert spectrometer was used to acquire the x-ray
diffraction spectrums. This method (Cuflity, 197$) consists of
an x-ray source on the left side and an x-ray detector on the
right side while the sample is located in the cdnter. The source
and the detector are rotating around the sample in a symmetri
cal way. Since the sample is made of powder, the crystals are
randomly oriented, a]lowing the diffraction of ail the atomic
planes. When there is diffraction, a larger amount of x-rays is
detected, creating a peak on the spectrum at the specific an
gle where the diffraction occurs. Each peak on the spectrum
corresponds to an atomic plane. The position of a peak on the
spectrum can be converted to the d spacing of the atomic p]ane
with the Bragg formula:
À = 2dsin8
whcre À is the wavelcngth of the x-rays, which is known, and
O is the position of the peak on the spectrum, which can be
measured. The d spacing of an atomic plane is the distance
between the atomic planes of the same type. When the dspacing
of the atomic planes is known, they can be identified by their
Miller indices. By comparing the results with a database of
known compounds, the sample analyzed can be identified.
R [S U L TS
The size distribution of the Mn phosphate/sulfate mixture
found in the inhalation chamber (Table 1) shows that about
68% of the particles are less than 0.93 im in size while 87%
are less than 3.5 ,im. These percentages are similar to those
obtained with Mn phosphate or Mn sulfate used alone in our
two othcr inhalation toxicology studies.
TABLE 1
Size distribution of Mn sulfate, Mn phosphate, and Mn
phosphate/sulfate mixture in the inhalation chamber
Particle size Mn sulfate Mn phosphate Mn phosphate!
(icm) (%) (%) sulfate mixture (%)
6.0—9.8 2.8 ± 0.2 3.6 ± 1.0 6.6 ± 2.7
3.5—6.0 3.5 + 0.9 8.5 + 2.3 6.2 ± 0.9
1.55—3.5 11.0 ± 2.8 8.3 ± 2.6 7.1 ± 0.1
0.93—1.55 35.2 + 9.8 13.2 + 1.9 12.7 ± 2.8
0.52—0.93 23.1 + 7.9 39.2 + 4.5 40.8 ± 5.1
<0.52 15.1 ± 4.6 18.4 ± 3.6 17.3 ± 1.8
BFU 9.4 + 0.6 8.9 ± 7.6 9.3 + 6.8
X-Ray Diffraction
Three powder samples were analyzed. The first one was the
Mn sulfate (Figure 1), which shows a specific peak at 25.5 on
the 2 theta axis with the highest intensity (100%). As for the
Mn phosphate (Figure 2), we observe two specific peaks, one
with the highest intensity (100%) at 26° on the 2 theta axis and
the other at 29.5° on the 2 theta axis with an intensity of 85%.
Figure 3 shows the results of the mixture (Mn phosphate!sulfate
mixture) used in our inhalation toxicology studies. We see the
specific peak of Mn sulfate (100%) at 25.5° on the 2 theta axis
and only one peak of the Mn phosphate at 28° on the 2 theta
axis with less intensity (85%) than before (100%). The other
peak of Mn phosphate at 29.5° on the 2 theta axis has a very
low intensity (near 38%).
SEM/EDS Characterization
Five fihters were analyzed for residual particles as collected
in the inhalation chamber. Hundreds of particles were analyzed
and characterized on the filters. Figure 4 shows an SEM micro
graph of one field. EDS analyses (Figures 5 to 12) show that the
elements present in ail the particles werc Mn, P, S, and 0. The
presence of oxygen suggests that we obtained Mn sulfate and
Mn phosphate. Carbon was aiso detected due to the coating.
Table 2 shows that 266 particles were anaiyzed. Thirty three
percent (33%) of the particies were found to be agglomerated,
while free particles totaled 118 for Mn phosphate and 60 for Mn
sulfate (see example in Figure 13). An average of 61% and 39%
ofthe manganese-containing particles were related to these Mn
chemical forms, respectively.
The spectrum shown in Figure 14 was acquired on a 4 mm2
region of the fiiter with an acquisition time of 600 s. It shows
the global chemical composition of the fiher. In addition 10 the
P, S, Mn, and O peaks, which are specific to the phosphate and
the sulfate powder particles; the spectrum also contains peaks
of C from the coating and F from the Teflon filter. The P peak
is more intense than the S peak. The ratio of the intensity PIS,
calculated after background subtraction, is 3.8.
TABLE 2
Number of particles observed in different classes
Free particles Agglomerated particles
Total Mn Mn Mn Mn
Filters analyzed phosphate sulfate phosphate sulfate
1 52 17 4 16 15
2 54 28 15 6 5
3 53 24 15 7 7
4 56 20 lI 13 12
5 51 29 15 3 4
Total 266 118 60 45 43
% 44 23 33B-F, backup filter.
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FIG. 1. X-ray diffraction pattem of manganese sulfate powder. The numbers are the Millet indices of the diffracting planes.
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FIG. 2. X-ray diffraction pattetn of manganese phosphate powder. The numbers are the Miller indices of the diffracting planes.
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FIG. 3. X-ray diffraction pattern of the mangancse sulfate/phosphate mixture. The numbers are the Miller indices of the diffracting
planes.
FIG. 4. SEM micrograph showing particles on the luter.
236 L. A. BEAUPRÉ ET AL.
750
500
cd,
250
O
750 -
Mn
500 -
250 -
-
‘
8 10
Energy (keV)
FIG. 6. X-ray ED$ spectrum of particle 2.
Mn
P
0 2
Mn
Energy (keV)
FIG. 5. X-ray EDS spectrum of particle J.
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FIG. 7. X-ray EDS spectrum of particle 3.
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FIG. 8. X-ray EDS spectrum of particle 4.
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FIG. 9. X-ray EDS spectrum of particle 5.
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FIG. 10. X-ray EDS spectrum of particle 6.
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FIG. 11. X-ray EDS spectrum ofparticle 7.
240 L. A. BEAUPRÉ ET AL.
A reference sample contairling the powder from the 50/50
(by weight) mix used was made. The powder was simply de
positcd on a carbon sample holder. figure 15 shows a picture
of the reference sampie. Considerabie aggiomeration of parti-
des could be observed and very few sulfate particles could be
found. Nearly ail the suifur detected was from aggiomerations
of phosphate and sulfate particles. The purpose of analyzing the
reference sample was to calculate the quantity of phosphate and
sulfate particles present in the mix and to compare it to what
was found on the filters. However, because of the high level of
aggiomeration on the reference sampie, the anaiysis of smaii
particles could flot be done. Nevertheless, it is obvious that par
ticles from the reference sample (Figure 15) are quite different
from those found in the inhalation chamber where they are less
agglomerated (figures 4 and 13). A spectrum was acquired un
der the sanie conditions as those used to acquire the spectra
on the filter (Figure 16). The PIS ratio calculatcd from the net
intensities of the spectrum is 3.4, which is lower than the one
acquired on the filter. This means that the filter contains less S
than the reference sample, which contains 50% (by weight) of
both powders. This may be due to the process used to produce
a ffow of air containing the panicles, which involves 100 m
brass beads to mix the powder with the airflow so that most of
the aggiomerations arc broken up because of the collisions be
tween the sand particles and the phosphate and sulfate particles.
One important point is the potential absorption of the S
x-rays by P, which couid explain the iower S intensity observcd
in most of the spectra acquired. This is because the mass ab
sorption coefficient of S x-rays by P is much higher than that
of the other values (sec Table 3). The critical thickness for 10%
TABLE 3
Mass absorption coefficients (cm2/g) of
P and S Kx x-ray unes
Emitter
Absorber P S
P 287.4 2230
S 370.9 254.6
FIG. 13. SEM micrograph showing particies containing phosphate and sulfate compounds.
Note. From Goldstein et al. (t992).
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FIG. 14. X-ray EDS spectrum acquired on a 4-mm2 region of the fi]ter. PIS ratio = 3.8.
of absorption of the S Kc x-rays by Mn phosphate and Mn sul
fate particles were calculated. The resuits are 316 and 334 nm,
respectively, which confirms that there is a strong absorption
of the S Kx x-rays, since alt the partictes analyzed in the SEM
are over 500 nm in size for Ihe particles both on the filter and
in the reference sample.
ATEM Characterization
A number of isolated particles and particle clusters retrieved
from the filter were characterized by ATEM. Figure 17 shows a
representativeTEM micrograph ofa particle cluster. The chem
ical composition determined by x-ray EDS was similar to that
determined in the SEM and consisted mainly ofMn, 0, P, and S,
regardless of whether the particles were isolated or in clusters.
This confirms that the particles are Mn phosphate and Mn su!
fate and that the ratio is the samc as that found with SEM, which
is 61% for Mn phosphate and 39% for Mn sulfate. The S and P
x-ray peaks detected in the ATEM will be subjected to the same
absorption phenomenon of the S Ko x-rays described for SEM
but to a lower level, since the size of the particles analyzed in
ATEM are smaller than those analyzed in SEM, as can be seen in
figure 17.
DISCUSSION
Figure I shows that the background of the x-ray diffraction
pattem is uniform, which indicates that the powdcr is smooth
and the particles are fine. As for Figure 2, the phosphate pow
der has a lower density, which wcakens the signal. This could
explain why in Figure 3, the second peak from the phosphate
powder has a very low intensity. X-ray diffraction is a method
that specifically associates the peacs with the compound; it is
like a fingerprint for each chemical compound. This technique
was used to verify the nature of the mixture. The SEM/EDS
technique, having good spatial resolution, allows one to observe
individual residual particles and to analyze their chemical com
position one by one. It allows analysis of the bigger particles
(>0.5 /Lm) and can identify the elements present in the particles.
ATEM has a much higher spatial resolution and can isolate and
characterize fine particles and particle clusters down to a size
of 0.1 Both techniques (SEM and ATEM) can identify the
elements that compose a particle but cannot readily detennine
if it is a sulfate unless detailed and complex (for the case studied
here) quantitative analysis is carried out. These techniques only
show that sulfur is present. Tue same applies to the phosphate
particles, where both techniques can only detemiine the pres
ence of phosphorus and flot the stoichiometry. The presence
C
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of oxygen, however, strongly suggests that the compounds are
sulfates and phosphates.
in this study, equal weights of Mn phosphate and Mn sul
fate were introduced into the inhalation chamber. However,
the subsequent analysis of air samples by electron microscopy
showcd that 39% of the particles were Mn sulfate and 61%
were Mn phosphate. This ratio is acceptable, since it is near
the ideal ratio of lit. During the pre-experiment, we took
into account the molecular weight of each substance to max
imize the probability of obtaining a ratio of 50/50 for par
ticles in the inhalation chamber. Since the molecular weight
(MW) are 728.65 and 169.03 for Mn phosphate and Mn sul
fate, respectivcly, representing a ratio of approximately 4/1,
we have used the inverse ratio for weight (4 Mn sulfate/1
Mn phosphate). Nevertheless, the proportion of particles for
each Mn species was far away from the target of 1/1. In fact,
more than 80% of the particles were related to the Mn sulfate
compound.
Moreover, the size of the particles before their entry into
the chamber could explain the results obtained in this study.
In fact, as prcsented in the method, Mn aerosol particles were
delivered through a stainless-steel pressure tank used for the
settling of larger Mn aerosol particles. Since we did flot charac
terize in detail the particles used in this study before their ently
into thc inhalation chamber, we can hypothesize that the Mn
sulfate particles in the powder used were bigger than those of
Mn phosphate. In fact, Table I shows a similar size distribu
tion of particles in the inhalation chamber for Mn sulfate, Mn
phosphate, or the mixture. This suggests that more Mn sulfate
particles settle in the steel tank because of their size, as found
in the powder.
The fact that the mixture of particles in the inhalation cham
ber was flot 50/50 could lead to an underestimation or to an
overestimation of the effects. In our study, only the rats exposed
to the Mn phosphate/sulfate mixture (and not to Mn phosphate
only) had significant changes in locomotricity compared to the
control rats (Normandin et al., in press). This is in agreement
with the results of some studies that showed that the solubility
of inhaled Mn particles may influence the brain Mn concen
trations (Normandin et al., 2002; Dorman et al., 2001). The
dissolution of water-soluble MnSO4 is more rapid than that of
water-insoluble MnHPO3 (Vitarella et al., 1997).
FIG. 15. Secondary clectron image in the SEM of phosphate and sulfate particles in the reference sample.
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fIG. 16. X-ray EDS spectrum acquired on the reference powder. Ratio PIS = 3.4.
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FIG. 17. ATEM analysis of a particle cluster observed on a filter.
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Overali, this study shows that it is very difficuit to reach the
target of 50% Mn sulfate/50% Mn phosphate mixture in the
inhalation chamber. Many factors could play an important role.
In terms of the assessment of various effects, the fact that the
number of Mn sulfate particles was about 22% less than that
of the number of Mn phosphate particles probably lcd to an
underestimation.
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